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To gain further understanding of leucine-sensitivity 
in Escherichia coli K-12, two recombinant plasmids were 
isolated; one carrying the leuR DNA fragment and the other 
carrying the putative jlvA* DNA fragment. In addition to 
conferring leuR, both recombinant plasmids conferred a 
valine resistant growth phenotype and generated a high 
level of TD activity in the mutant strain PS1150. 
However, the the multivalent attenuation control signal 
appeared non-functional in the mutant PS1150, as well as, 
in PS1150 transformants. Both the leuR and putative ilvA* 
plasmids appeared to direct the synthesis of proteins in 
the 100 and 200 KDa range. Additionally, repression 
studies strongly suggest that there is another mutation 
in the leus mutant which is responsible for the altered 
control of the ilvA gene. 
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The biosynthesis of leucine, isoleucine, and valine 
in Escherichia coli K-12, occurs through a branched 
pathway leading to leucine biosynthesis and involves the 
participation of common precursors and shared enzymes 
(Figure 1). These enzymes are encoded by several 
independent opérons including the ilvGMEDA operon which 
is regulated by a multivalent attenuation mechanism (Hsu 
et al., 1985; Landick et al., 1987; Lawther and Hatfield, 
1980; Umbarger, 1978; Yanofsky, 1981). 
Previously, reports have indicated that the ilvA gene 
product, threonine deaminase, is an autoregulatory protein 
that controls the expression of its own gene and those 
coding for other ilv biosynthetic genes (Calhoun et al., 
1974 and Calhoun et al., 1975). Hatfield and Burns (1970) 
proposed an autoregulatory model that explains the 
multivalent repression mechanism observed in the ilv 
biosynthetic operon when the branched-chain amino acids 
are present in excess. Using purified preparations of 
threonine deaminase, they demonstrated that the addition 
of pyridoxal phosphate results in the formation of the 
1 
Figure 1. Branched-chain amino acid biosynthetic 
pathway. Pertinent abbreviations are as 
follows: TD, threonine deaminase; AHAS, 
acetohydroxy acid synthase; IR, acetohydroxy 
acid isomeroreductase; DH, dihydroxy acid 
dehydrase; TrB, transaminase B. The genes 
encoding each of these enzymes are indicated 
next to the enzyme. The chromosomal 
locations are indicated below. The ilvY gene 
encodes a positive activator of ilvC 
transcription. Arrows indicate the direction 
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immature form of threonine deaminase (inactive). In the 
presence of either valine or isoleucine, the immature 
holoenzyme is converted to the mature form (active), but 
the addition of both isoleucine and valine inhibited the 
maturation process and the immature form is maintained. 
More importantly, the binding of leucyl-tRNA to the 
immature form of threonine deaminase served as a 
repression signal for the ilv biosynthetic genes (Hatfield 
and Burns, 1970), but based upon amicon ultrafiltration 
the binding of isoleucyl- and valyl-tRNA's to the immature 
form of threonine deaminase was also observed (Calhoun, 
unpublished commun.). Levinthal et al. (1973) studied 
the autoregulatory role of threonine deaminase by the 
isolation of a leucine-sensitive Escherichia coli K-12 
mutant strain which carries the ilvA538 regulatory 
mutation in the structural gene for threonine deaminase. 
In a strain carrying this mutation, the expression of the 
ilvGMEDA operon was decreased as well as the expression 
and/or activity of isoleucyl- and valyl-tRNA synthetases. 
Also, there was a loss in the multivalent attenuation 
control mechanism in this mutant (Levinthal et al., 1976) . 
Further, Levinthal and collaborators (1976) reported that 
this mutant had reduced levels of the branched-chain amino 
acyl-tRNA synthetases under repressing conditions and 
4 
their synthesis in minimal-glucose medium was below normal 
levels. Later, Calhoun (1976) reported the isolation of 
several leucine resistant derivatives of PS187 (ilvA538). 
Two of these spontaneous derivatives produced a threonine 
deaminase that was more resistant to isoleucine than the 
wild type, and intermediate between the wild type and the 
mutant strain with respect to leucine inhibition. 
Threonine deaminase and dihydroxy acid dehydrase 
activities were lower than normal in these derivatives. 
Some of the other leucine resistant derivatives produced 
increased levels of the feedback hypersensitive threonine 
deaminase. From these data, Calhoun concluded that the 
leucine sensitive growth phenotype of the mutant appeared 
to be related to the feedback hypersensitivity of 
threonine deaminase and to the low expression of the ilv 
genes. Thus, the ilvA538 regulatory mutation appeared to 
affect the catalytic and regulatory properties of 
threonine deaminase. Furthermore, in studies reported by 
Hahn and Calhoun (1978), fifty-eight derivatives of PS187 
(ilvA538) were isolated as being growth resistant to 
leucine, valine or valine plus glycyl-valine. All of 
these derivatives produced a feedback hypersensitive 
threonine deaminase. Among the eighteen analyzed, only 
those with mutations linked to the ilv gene cluster 
5 
produced elevated levels of threonine deaminase. A MSR91 
derivative which was resistant to valine plus glycyl- 
valine was analyzed genetically. In this derivative, the 
synthesis of the ilvEDA gene products was constitutive and 
derepressed about 200 fold relative to the wild type. 
These data suggested that the ilvA538 allele had been 
suppressed therefore, resulting in derepression of the 
ilvEDA gene products. 
Presently, the molecular basis for the leucine- 
sensitive phenotype in a strain carrying the ilvA538 
regulatory mutation remains unknown. Several studies 
have focused on the autoregulatory role of threonine 
deaminase with respect to the ilv biosynthetic operon. 
For further understanding of threonine deaminase's role 
in the autoregulatory process, the leucine-sensitive 
strain, PS1150, which carries the ilvA538 regulatory 
mutation, was isolated (Levinthal et al. , 1973). Several 
researchers have reported that in a strain carrying this 
mutation, the expression of the ilvGMEDA operon was 
reduced as well as the activity and/or expression of 
isoleucyl-and valyl-tRNA synthetases (Levinthal et al., 
1973 and Levinthal et al., 1976). Another property that 
has not been studied extensively is the leucine-sensitive 
growth phenotype of the ilvA538 mutant. Calhoun (1976) 
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suggested that the leucine-sensitive growth phenotype 
appeared to be related to the hypersensitivity of 
threonine deaminase to isoleucine and to the low 
expression of the ilv genes. Later Calhoun and Gray 
(1982) reported on the cloning of the ilvA538 gene which 
codes for feedback-hypersensitive threonine deaminase. 
Based upon deletion mapping experiments using \ dilv 
phage, these authors reported that the ilvA538 mutation 
conferred the loss of the repression control of the 
ilvGMEDA operon. It was further suggested that additional 
mutation(s) may be present that contribute to the reduced 
enzyme levels in a strain carrying the ilvA538 mutation. 
More recently, Taillon et al. (1988) presented data on the 
nucleotide sequence of the ilvA538 allele. These data 
indicated a change in base pair 950 (i.e., C -to- T 
transition) leading to the replacement of alanine-317 with 
valine. Further, the molecular basis for valine 
resistance in Escherichia coli K-12 has been elucidated 
by the contributions of Lawther et al. (1981, 1982) . With 
the employment of nucleotide sequencing, they revealed 
that the wild type EL. coli K-12 strain contains a 
frameshift mutation within the ilvG gene (for valine 
sensitivity) , and the ilvG'f2096 mutation displaces the 
7 
frameshift site resulting in the expression of the ilvG 
gene (for valine resistance). 
In this study, we report the cloning and 
characterization of two recombinant plasmids (leuR and 
ilvA*) which conferred identical properties (leuR, valR 
and ilvA) to two well established mutant strains, PS1150 
(leus) and CU406 ( ilvA') . Along with conferring these 
properties, the expression of the ilvA gene and the 
activities of isoleucyl- and valyl-tRNA synthetases were 
restored to normal levels. The multivalent attenuation 
control mechanism appeared non-functional in these clones, 
suggesting that the mutant may contain another mutation 
which may be responsible for regulation of the ilvA gene 
expression. Further, plasmid pRL258 carrying the ilvA* 
gene of Lawther (1987) was used to transform the mutant 
strain PS1150. After transformation, plasmid pRL258 was 
unable to confer either of the properties (leuR or valR) 
to the mutant strain PS1150. There is a strong indication 
that the expression of the ilvA gene in these clones is 
probably enhanced by additional sequences, which confer 
both leuR and valR. These observations suggest that the 
recombinant plasmids used in this study may contain 
similar DNA inserts which are responsible for the 
expression of leuR, valR, and ilvA* phenotypes. 
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Since neither the leuR or the ilvA* fragment (s) 
restored the multivalent attenuation control mechanism to 
the mutant PS1150, we propose that there is an additional 
mutation in the attenuator region of the leader. A second 
mutation could account for the altered regulation of the 
ilvGMEDA operon and isoleucyl- and valyl-tRNA synthetase 





Regulation at the Operator/Promoter Region: 
The initial evidence of genetic regulation of 
bacterial opérons emerged through the contributions of 
Jacob and Monod. Jacob and Monod (1961) postulated a 
regulatory model, which described genetic regulation of 
lactose utilization in Escherichia coli. and depicted the 
existence of two types of regulatory effectors that 
control gene expression (Jacob and Monod, 1961). 
Inducers, which are small regulatory effectors, function 
by interacting with specific repressor molecules, thereby 
preventing operator-repressor interaction and allowing 
transcription initiation to occur (induction). In 
contrast, repressor molecules function by forming a 
repressor-operator complex which prevents transcription 
initiation at the promoter/operator region (repression). 
This repressible regulatory mechanism proposed by Jacob 
and Monod provided the basis for understanding genetic 
regulation of amino acid biosynthetic opérons in 
prokaryotes. The tryptophan operon that codes for the 
enzymes responsible for tryptophan biosynthesis is 
9 
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regulated via this repressible regulatory mechanism. 
Regulation of this operon occurs by a tryptophan-activated 
repressor protein which regulates transcription initiation 
by controlling the access offi RNA polymerase to the 
promoter/operator region (Jacob and Monod, 1961) . Johnson 
and collaborators (1983) have demonstrated by using 
mutants and by identifying tryptophan operator like 
sequences in thr. leu, and ilv opérons, that repression 
may play a regulatory role in these opérons. Further 
studies have indicated that ileR* encodes a repressor 
protein that exerts negative control on thr and ilv 
opérons (Johnson et al., 1984). Additionally, positive 
effectors have been shown to regulate amino acid 
biosynthetic opérons. Guanosine 5' diphosphate 3' 
diphosphate (ppGpp), a positive effector, functions by 
controlling the rate of stable RNA (i.e. rRNA and tRNA) 
synthesis with respect to amino acid availability for 
protein synthesis (Cashel and Rudd, 1987). Stephens et 
al. (1975) have shown that guanosine tetraphosphate 
(ppGpp) served as a positive effector for transcription 
initiation of the histidine operon. Also, regulation of 
the tryptophan operon has been coupled to guanosine 
tetraphosphate control, which stimulated its expression 
in an in vitro system (Yanofsky et al., 1982). 
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Cyclic adenosine 3'5' monophosphate (cAMP), another 
positive effector, is synthesized primarily in response 
to a carbon deficiency within the cell. Cyclic AMP is 
involved in the regulation of the ilvBN biosynthetic 
operon that codes for the isozyme acetohydroxy acid 
synthase I (AHAS I) which participates in the biosynthesis 
of the branched-chain amino acids (Gardner, 1979; Sutton 
et al.. 1980; Williams, 1983). Also, Lopes et al. (1989) 
reported cAMP binding sites in the internal promoter 
region of the ilvA gene. 
Regulation at the Attenuator Region: 
In addition to regulation at the transcription 
initiation level, several reports have shown that a 
regulatory mechanism occurs at the transcription 
termination level for several amino acid biosynthetic 
opérons. An attenuation control mechanism has been 
reported for several amino acid biosynthetic opérons: trp 
(Landick et al., 1987; Yanofsky, 1981; Yanofsky et al.. 
1982), phe (Landick et al. . 1987), his (Barnes, 1978 and 
Dinocera et al. . 1978), leu (Gemmill et al.. 1979), thr 
(Gardner, 1979), ilvBN (Hauser et al., 1984 and Hauser et 
al., 1985), and ilvGMEDA (Hsu et al., 1975; Landick and 
Yanofsky, 1987; Lawther et al., 1987; Lawther et al. . 
1980; Lawther et al.. 1987; Yanofsky et al., 1982) of E. 
12 
coli K-12. This regulator of transcription termination 
is the attenuator that controls transcription termination 
at the site preceding the first structural gene of the 
operon. The rate of translation of the leader transcript 
is dependent on the levels of the corresponding amino acid 
and the levels of their cognate aminoacyl-tRNA. The 
formation of leader RNA secondary structures determines 
whether transcription into the structural genes or 
transcription termination will occur (Hauser et al., 
1985). 
Aminoacyl-tRNA synthetases have also been shown to 
participate in regulating gene expression in amino acid 
biosynthetic opérons. These enzymes are responsible for 
the acylation of tRNAs and they play a role in 
maintaining the levels of aminoacylated tRNAs, which 
regulate transcription termination. Neidhardt et al. 
(1975) demonstrated that aminoacyl-tRNA synthetase levels 
were increased with increasing cellular growth. Other 
studies have indicated that the regulation of 
aminoacyl-tRNA synthetase gene expression occurred by 
controlling the levels of their cognate amino acids. 
Several aminoacyl-tRNA synthetases displayed transient or 
permanent derepression when starved for their cognate 
amino acids (Neidhardt et al. , 1977). Putney and Schimmel 
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(1981) have suggested a mechanism for regulation of 
alanyl-tRNA synthetase gene expression. In vitro. 
alanyl-tRNA synthetase was shown to repress transcription 
of its own gene by binding to a palindrome region at the 
alaS promoter region. Similarly, the expression of 
threonyl-tRNA synthetase is autoregulated, but regulation 
occurs at the post-transcriptional level by the binding 
of this enzyme to the 5' end of thrS mRNA; thereby, 
inhibiting the translation of the thrS gene transcript 
(Bulter et al., 1986). Phenylalanyl-tRNA synthetase gene 
is regulated by translational control of transcription 
termination at the attenuator site preceding the pheS gene 
which responds to intracellular aminoacylated tRNA phe 
(Fayat et al.. 1983 and Springer et al., 1983). 
Presently, studies at the molecular level regarding 
the regulation of isoleucyl-, valyl-, and leucyl-tRNA 
synthetases are unknown, but work in this area has 
included identification of promoters and comparison of 
sequence homology between the other known synthetases. 
Studies by McGinnis et al. (1971) demonstrated that the 
branched-chain aminoacyl-tRNA synthetases were regulated 
via a multivalent repression mechanism. In theses 
studies, valyl-tRNA synthetase formation was shown to be 
multivalently regulated by isoleucine and valine, whereas 
14 
repression control of isoleucyl- and leucyl-tRNA 
synthetases was mediated by the supply of their cognate 
amino acids. 
Further evidence for the regulation of isoleucyl- and 
valyl-tRNA synthetases came from the studies using ilvA 
mutant strain of E. coli (Levinthal et al., 1973 and 
Levinthal et al, 1976). Levinthal et al. (1973) first 
demonstrated that the ilvA gene product, threonine 
deaminase, was involved in regulating isoleucyl-, leucyl-, 
and valyl-tRNA synthetases formation. Williams et al. 
(1978) have shown by using an ilvDAC deletion strain 
carrying the ilv operon that the levels of the branched- 
chain aminoacyl-tRNA synthetases were comparable to those 
in the normal strain. Also, the regulation of synthesis 
required one of the products missing in the deletion 
strain and the evidence strongly suggested that the 
product was threonine deaminase. Later, Singer et al. 
(1984) presented evidence for the in vitro inhibition of 
isoleucyl- and valyl-tRNA synthetases activity by 
threonine deaminase and 2-ketobutyrate, the product of the 
threonine deaminase reaction, through the formation of 
high molecular weight complex of the three molecules. 
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Williams et al. (1985) reported evidence for cAMP- 
mediated control of isoleucyl-tRNA synthetase formation. 
More recently, studies of Miller and Wu (1987) 
demonstrated that the ileS and lsp genes were 
cotranscribed during log phase growth, but their 
transcription may be uncoupled under other physiological 
conditions. Studies of Heck and Hatfield (1988) revealed 
that the vais transcriptional unit consisted of two 
promoters and a rho-independent transcription termination 
site. Additional evidence is reguired to elucidate a 
mechanism responsible for its regulation. Hartlein and 
Madern (1987) reported on the molecular cloning and 
seguencing of the leucyl-tRNA synthetase gene. Sequence 
comparison studies of the leuS sequence with all the amino 
acyl-tRNA synthetase sequences revealed a significant 
homology with valyl-, isoleucyl-, methionyl-tRNA 
synthetase genes which suggested that these synthetases 
were derived from a common ancestor. 
Biosynthesis of Branched-Chain Amino Acids 
In E. coli K-12, the biosynthesis of isoleucine, 
leucine and valine occurs through a branched pathway 
leading to leucine biosynthesis and involves the 
participation of common precursors and shared enzymes. 
These shared enzymes are encoded by several independent 
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opérons including the ilvGMEDA operon. This operon is 
regulated by a multivalent attenuation mechanism (Hsu et 
al. . 1985; Landick et al. . 1987; Lawther and Hatfield, 
1980; Umbarger, 1978; Yanofsky, 1981). The first enzyme 
of the isoleucine pathway, threonine deaminase, is encoded 
by this operon. This enzyme catalyzes the deamination of 
threonine to form a-ketobutyrate, followed by the 
condensation of a-ketobutyrate with pyruvate to yield a- 
acetohydroxy butyrate. Valine biosynthesis occurs with 
the condensation of two pyruvate molecules yielding a- 
acetolactate. The remaining reactions of the isoleucine 
and valine pathway are catalyzed by shared enzymes (Figure 
1). In addition, the keto acid precursor in the valine 
pathway, a-ketoisovalerate, is the branched point 
intermediate in the pathway. At this point, a- 
ketoisovalerate can be converted to leucine by four 
enzymes encoded by genes in the leucine operon or to 
valine by the enzyme transaminase B (ilvE). 
Regulation of the ilvGMEDA Operon 
Transcription Initiation: 
The ilvGMEDA operon is regulated at the transcription 
initiation level by two main promoters (PI and P2) and by 
several internal promoters. In vitro, the proximal 
promoter regions have been shown to consists of promoters 
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PI and P2, which are separated by 72 base pairs (Lawther 
et al., 1980). Similarly, in vitro studies of Adams et 
al. (Adams et al. . 1980) demonstrated that RNA polymerase 
initiated transcription at the PI promoter 50% more than 
at the downstream promoter P2. Further, RNA finger 
printing analysis of in vivo transcripts from the ilvGMEDA 
attenuator region revealed that less than 1% of the in 
vivo transcription initiates at the PI promoter during 
several growth conditions that affect operon expression. 
However, using multicopy qalK transcriptional 
fusions, it was demonstrated that sequences upstream of 
the P2 promoter were required for maximal expression in 
vivo (Lawther et al., 1980). 
In addition to transcriptional promoters at the 
beginning of the operon, internal promoters have been 
described for several opérons in E. coli (Wek and 
Hatfield, 1986). Two functional roles have been described 
for these promoters: to regulate and to maintain a basal 
level of expression of the operon distal genes. Wek and 
Hatfield (1986) presented evidence for the PE promoter, 
which is located in the distal portion of the ilvM gene 
of E. coli. Based on galK transcriptional fusions, the PE 
promoter is 52-fold weaker than the operon- PI and P2 
promoters. It appeared that the contribution of the PE 
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promoter was to maintain a basal level of operon-distal 
gene expression within the ilvGMEDA operon during certain 
growth conditions. Moreover, reports have shown that 
other internal promoters exists, PD and PA located 
upstream of the ilvD and ilvA genes of E. coli (Calhoun 
et al., 1985). Further, studies of Lopes and Lawther 
(1989) revealed the existence of the PA promoter, located 
distal to the coding sequence of the ilvD gene, using aalK 
transcriptional fusions. 
Multivalent Attenuation: 
The ilvGMEDA operon is regulated multivalently by the 
levels of aminoacylated tRNA'le, tRNAleu, and tRNAval 
(Lawther et al., 1987). Multivalent regulation of the 
ilvGMEDA operon is mediated by attenuation that involves 
the synthesis of a 32-residue peptide containing 6 valine, 
5 isoleucine, and 5 leucine residues (Landick and 
Yanofsky, 1987 and Lawther et al., 1987). The leader 
region 270 nucleotides in length yields a 185 nucleotide 
terminated transcript which has the potential to fold into 
secondary structures. 
To explain ilv attenuation, Hauser et al., (1985) 
proposed that when a ribosome stalls at the top of the 1:2 
stem loop, a second ribosome initiates synthesis of the 
leader peptide on the same transcript and encounters the 
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stalled ribosome. Therefore, blocking the bottom of the 
1:2 stem loop and facilitating deattenuation, but evidence 
of a transcriptional pause site near the base of stem loop 
1:2 sheds some doubt on this model. This model is 
referred to as the double-ribosome model and has been 
applied to the ilvBN operon regulation. An alternative 
explanation is that the initial translating ribosome 
stalls at the bottom of the 1:2 stem loop, which 
destablizes the 1:2 stem loop, and separates the remaining 
complementary bases; therefore, base pairing of 
the unmasked sequences leads to the formation of the anti¬ 
terminator stem loop 2:3. 
More recently, Lawther (1989) reported on point 
mutations in the regulatory region of the ilvGMEDA operon. 
These mutations confirmed previous conclusions about the 
ilv regulatory region. Further, mutation ilvGp2950 
reduced both the expression in vivo and the transcription 
in vitro of galactokinase. Analysis of other mutations 
(ilvGe952 and ilvGa951) suggested that the site of 
translation initiation and the site for the formation of 
the stem-loop required for transcription termination was 
consistent with previous reports. Later, Lawther et al. 
(1990) demonstrated that the decrease in expression of the 
ilv genes (upon the addition of ILV) was not modulated at 
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transcription initiation, but occurs at the leader region. 
The addition of all three amino acids to minimal medium 
resulted in a 5-7-fold reduction of galactokinase 
expression when aalK was fused to the ilv regulatory 
region. 
Transcription Termination at the End of the Operon: 
The transcriptional apparatus of cells utilizes 
another mechanism to control mRNA termination, and its 
regulation of transcription termination occurs at the 3' 
end of the operon. The ilvGMEDA operon contains a 
possible rho-independent terminator centered around 
nucleotide 6686 (Platt et al., 1986). In vitro 
transcription experiments utilizing a restriction fragment 
containing the rho region fused to the tac promoter 
indicate a rho independent termination site. 
Structural Genes of the ilvGMEDA Operon 
The structural genes for the biosynthesis of 
isoleucine, leucine, and valine were divided into several 
transcriptional units located at three sites on the E. 
coli K-12 genome (2 min, 82 min, and 85 min). The first 
step in the biosynthesis of valine and the second step in 
isoleucine biosynthesis are catalyzed by the isozymes of 
acetohyroxy acid synthase I,II, III (Landick and Yanofsky, 
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1987) . The carbon flow through out the isoleucine and 
valine pathways is regulated by valine. Acetohydroxy acid 
synthases I and III are strongly inhibited by valine; 
whereas, acetohydroxy acid synthase II is insensitive to 
inhibition by valine. In E. coli K-12, the genes that 
code for AHAS I and AHAS III are expressed, but the genes 
that code for AHAS II are not. AHAS II (ilvGM) is not 
expressed because of a frameshift mutation in the ilvG 
gene which codes for the large subunit of the enzyme 
(Lawther et al., 1981 and Lawther et al., 1982). 
Consequently, exogenous valine inhibits total AHAS 
activity in E. coli K-12, resulting in starvation for the 
other end products of the ilv biosynthetic pathway. 
The three acetohydroxy acid synthase isozymes differ 
with respect to their catalytic, biochemical, and 
regulatory properties. The ilvBN operon encodes the 
structural gene for AHAS I and it is located at 82 minutes 
on the E. coli K-12 chromosome, approximately 2.6 minutes 
away from the other ilv genes (Bachman, 1990). The ilvBN 
gene product, AHAS I, has been purified and it exists in 
the dimer form with a molecular weight of 120,000 daltons 
(Umbarger, 1987). Regulation of the ilvBN operon is 
complicated by two regulatory mechanisms. End product 
repression is involved in ilvBN regulation, thus limiting 
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either valine or leucine results in an increase in AHAS 
activity (Landick and Yanofsky, 1987). This operon is 
also controlled by an attenuation mechanism which is 
regulated by the intracellular levels of aminoacylated 
tRNAval and tRNAleu (Friden et al., 1982 and Hauser et al. . 
1984) . In addition to the attenuation mechanism control, 
positive effectors such as cAMP and its receptor protein 
(Friden et al. , 1982 and Sutton et al. , 1980) , and 
guanosine tetraphosphate (Friden et al., 1982) have been 
reported to be involved in ilvBN regulation. 
Moreover, the ilvIH operon, which encodes the other 
valine sensitive isozyme is located about 2 minutes on the 
E. coli K-12 chromosome (Bachman, 1990). This operon is 
closely linked to the leucine operon and AHAS III 
formation is regulated by leucine. Early studies have 
shown that the ilvIH and leu opérons are linked on the 
same transcriptional unit (Squires et al. , 1981). Squires 
et al. (1981) demonstrated by studying the physical 
organization and regulation of the ilvIH operon in 
relation to the leu operon, that the ilvIH and leu opérons 
are two distinct opérons. Also, they are separated by 
1,500 base pairs and transcribed in opposite directions. 
More recently, Ricca et al. (1989) demonstrated that a 
protein may be responsible for the expression of the ilvIH 
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operon and its binding is regulated by leucine. Studies 
of Platko et al. (1990) identified a gene that codes for 
the Lrp protein, which is responsible for the expression 
of the ilvIH operon. This gene is identical to the oppl 
gene that negatively regulates the oppABCDF operon. The 
Lrp protein activates the ilvIH operon and represses the 
OPPABCDF operon expression. 
The third isozyme, AHAS II is encoded by the ilvG and 
ilvM genes which are linked to the ilvGMEDA operon and are 
located about 85 min on the EL coli chromosome. This 
valine resistant isozyme is a tetramer composed of two 
large and two small subunits with molecular weights of 
59,300 (ilvG) and 9,700 (ilvM) (Umbarger, 1987). Since 
these genes are linked to the ilvGMEDA operon, they are 
regulated by a multivalent attenuation mechanism. Lawther 
and others (1981 and 1982) showed by seguencing the wild 
type EL. coli K-12 ilvG gene and the ilvG gene from an 
ilvG'l'2096 mutant, that expression requires a deletion or 
an addition of two bases to displace the frameshift 
mutation in the wild type EL. coli K-12. The ilvE gene 
product, transaminase B, catalyzes the last reaction in 
the isoleucine, leucine and valine biosynthetic pathways 
(Figure 1). Transaminase B has been purified to 
apparent homogeneity and characterized as a hexamer of 
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identical subunits with molecular weights of 32,000 
daltons (Lee-Peng et al., 1979) . The ilvE gene is 
regulated by the same mechanisms as the ilvGMEDA operon. 
Studies of Kline et al. (1977) indicated that in a strain 
lacking threonine deaminase, transaminase B was 
multivalently repressed by valine, isoleucine, and 
leucine. 
The enzyme dihydroxy acid dehydrase is coded by the 
ilvD gene, which catalyzes the dehydration of 
a,/3-dihydroxy acids of both isoleucine and valine pathways 
to yield the ketoacids a-keto /3-methylvalerate and 
a-ketoisovalerate (Figure 1) . The protein encoded by this 
gene has a molecular weight of approximately 66,000 
determined by electrophoresis of labeled maxicell products 
(Gray et al., 1981 and Uzan et al. , 1981) , and its 
regulation occurs by the same mechanisms as the operon. 
The most distal gene of the ilvGMEDA operon, ilvA. 
encodes the enzyme threonine deaminase which catalyzes the 
first enzymatic step in the isoleucine pathway. The 
carbon flow through this pathway is regulated by 
isoleucine via end product inhibition of threonine 
deaminase. Isoleucine inhibition is reversed by valine 
which acts as a positive effector (Umbarger, 1978). 
Threonine deaminase has been purified and it is a tetramer 
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of identical subunits with a molecular weight of 200,000 
daltons as determined by SDS gel electrophoresis (Calhoun 
et al., 1974). This enzyme is composed of one functional 
activator site (at which valine or threonine binds) and 
other allosteric sites for the binding of isoleucine and 
pyridoxal phosphate (coenzyme). The coopérâtivity of 
threonine binding to the active site results when 
isoleucine is present, but in the presence of valine this 
binding is eliminated. Several reports have indicated 
that threonine deaminase participates in genetic 
regulation as an autoregulatory protein. Calhoun and 
Hatfield (1975) concluded that threonine deaminase has 
repressor properties while Levinthal et al. (1976) 
reported that threonine deaminase's role is essentially 
a positive one. Guardiola et al. (1978) demonstrated by 
using two types of mutants (ilvA624 negative effector, 
ilvA625 positive effector) that threonine deaminase 
functions as a positive effector as well as a negative 
effector. 
CHAPTER III 
MATERIALS AND METHODS 
The bacterial strains used in this investigation are 
listed in Table 1. All bacterial strains were derivatives 
of Escherichia coli K-12. Plasmid pBR322 was used as the 
cloning vector (Bolivar et al., 1977). PI CM phage was 
used for genetic mapping by cotransductional analysis 
(Rosner, 1972). 
Media and Methods of Cultivation 
Luria-Bertani (L-broth) (Maniatis et al. , 1982), 
nutrient broth (Difco Laboratories), and minimal-glucose 
medium (Fraenkel et al., 1961) supplemented with 0.5% 
glucose and 0.2% ammonium sulfate as carbon and nitrogen 
sources, respectively, were used as liquid culture media. 
The media were solidified with 1.5% agar. 
Construction of Recombinant Plasmids 
The cloning of both recombinant plasmids are shown 
in Figures 2 and 3. Genomic DNA of an Escherichia coli 
K-12 strain, PS1079, was digested with restriction enzyme 
Sau3A and plasmid pBR322 was digested with BamHI in 




E. coli K-12 strains and Plasmids Used. 
Strain Genotype Source or 
Reference 
PS1079 ara. rbsll5. xvl-7. 
lacYl. malP. HfrP053 
M. Levinthal 
PSI150 ara. rbsll5. xvl-7. 
lacYl. malP. ilvA538. 
HfrP053 
M. Levinthal 
PS1151 ara. rbsll5. xvl-7. 






PS1152 ara. rbsll5. xvl-7. 






PS1153 ara. rbsll5. xvl-7. 
lacYl. malP. ilvA538. 





CSR603 F’, thr-1. leuB6. 
ohr-1. recA. araE3 
uvrA6. ara-H, lacYl. 
aalK2.xvl-5. mtl-1. 
rosL-31. tsx-33. SUPE-44. 
Sancar et al. 
CU 4 aalT12 D. Smolin 
CU4 06 aalT12. ilvA454 Laboratory stock 
AU589 ilvA538/ADr. Tcs. Leur This study 
AU589-2 ilvA538/Aprr Tc% Leu
r This study 
ilvA538/Apr. Tcr 
Valr 



















ilvA538/ADr. Tcr. Leu 
Valr 
r 
/ This study 
aalT12. ilvÀ454/Aor. 
Leur 
Tcs, This study 
cralT12. ilvA454/ADr. Tcs, This study 
aalT12. ilvA454/Anr. 
Valr 
Tcr, This study 
aalT12. ilvA454/ADr. 
Valr 
Tcr, This study 
ilvA538/ADr. Tcr. ilvA This study 
cralT12 . ilvA454/ADr. 
ilvA+ 
Tcr, This study 








Apr, Tcr Laboratory stock 
Apr, Tcs, Leur This study 
Apr, Tcr. ilvA+ This study 
Apr, ilvD: ilvA+: ilvY Robert Lawther 
Apr , Tcr, Leur, Valr This study 
Apr, Tcr, Leur, Valr This study pCH8 
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mixtures were pooled together and precipitated with 95% 
ethanol at -20°C. Following precipitation, the DNA was 
collected by centrifugation. Then resuspended in 100 nl 
of ligation buffer and 2 0 units of T4 ligase were added to 
the reaction mixture. The reaction was incubated at 12°C 
for 24 h (Maniatis et al. . 1982). The ligation was 
verified by agarose gel electrophoresis. The 
electrophoresis buffer was Tris acetate (0.04 M Tris 
acetate and 0.001 M EDTA). For ilvA* recombinant plasmid 
constructions, the same protocol was followed except that 
genomic DNA from PS1079 and plasmid pBR322 were both 
digested with restriction enzyme Hindlll in separate 
Eppendorff tubes. The cloning of pRL258 is shown in 
Figure 4. Wild type genomic DNA was digested with 
restriction enzymes Xhol and BallI and plasmid pUC9 was 
digested with Sail and BamHI in separate Eppendorff tubes. 
Both reaction mixtures were pooled together and 
precipitated with 95% ETOH. Following precipitation, the 
DNA was collected by centrifugation, resuspended in 
ligation buffer and T4 DNA ligase was added to the 
mixture. The mixture was then incubated at 12°C. 
30 
Transformation and Selection 
Bacterial cells were transformed according to the 
methods of Maniatis et al. (1982). Escherichia coli K-12 
strain PS1150 was grown to early log phase in L-broth 
containing 10 g tryptone, 5 g yeast extract, 5 g NaCl and 
1 g glucose per liter. Cells were chilled on ice for 10 
min, centrifuged, and washed in 1/2 the original volume 
of CaCl2 solution containing 50 mM CaCl2 and 10 mM Tris- 
HC1, pH 8. The cell suspension was centrifuged at 7 K rpm 
for 5 min at 4°C. Following the centrifugation, the 
suspension was chilled on ice for 15 min and then the 
cells were centrifuged. Subsequent to centrifugation, the 
cells were resuspended in 1/15 the original volume of 
CaCl2. Three separate Eppendorff tubes containing 0.2 ml 
competent cells of PS1150, 50 /il of ligation mixture/0.2 
ml competent cells of PS1150, and 50 /il of diluted 
pBR322/0.2 ml competent cells of PS1150 were used. The 
reaction mixtures were placed on ice for 30 min and then 
transferred to a 42°C water bath for 2 min. Following the 
incubation, cells were inoculated into 1 ml of L-broth and 
incubated for 1 h at 37°C. Cells were plated onto 
nutrient agar plates containing 50 /ig/ml of ampicillin. 
Colonies that grew on ampicillin plates were replica 
plated onto both ampicillin (50 /ig/ml) and tetracycline 
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(25 ng/ml) plates, and incubated at 37°C overnight. Apr 
and Tcs colonies were replica plated onto minimal-glucose 
plates containing 50 /xg/ml of L-leucine. The selection 
for the ilvA* recombinant plasmid was similar except that 
CU406 (ilvA~) competent cells were used in the trans¬ 
formation. Apr and Tcr colonies were selected and tested 
for threonine deaminase activity, the product of the ilvA 
gene. After the initial selection for both recombinant 
plasmids, each plasmid was transformed into either PS1150 
(leus) or CU406 (ilvAl) strains. Selection of the ilvA+ 
plasmid (pRL258) of Lawther (1987) was the same as the 
ilvA* recombinant plasmid in that CU406 competent cells 
were used in the transformation. Apr colonies were 
selected and tested for threonine deaminase. 
Growth Conditions of Clones 
Cells were grown in minimal-glucose media at 37°C 
under constant aeration on a rotary shaker. Growth was 
measured by monitoring an increase in optical density at 
420 nm on a LKB spectrophotometer for 6 h. To early log 
phase cells, the amino acids leucine (50 /zg/ml) , valine 
(100 /xg/ml) , and/or isoleucine (50 /xg/ml) were added to 
the growth medium. 
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Biosynthetic Enzvme Assays 
Cells were grown in minimal-glucose medium to late 
log phase, collected by centrifugation (10 K rpm) and 
resuspended in 3 ml of 0.05 M KP04 buffer containing 
1.5 X 10'4, L-isoleucine, pH 8. Following resuspension, 
the cells were subjected to sonic treatment with an 
Ultrasonic sonicator (Model W-220) for 30 sec with cooling 
on ice every 15 sec. The cellular debris was removed by 
centrifugation at 10 K rpm for 15 min at 4°C. The protein 
content of each extract was determined by the method of 
Lowry et al. (1951) using BSA as the standard. 
Threonine deaminase: The threonine deaminase assay was 
performed by the methods of Umbarger and Brown (1958) 
under the following conditions. Assays were carried out 
in a total volume of 1 ml and the reaction mixture 
contained 0.1 ml of 1 M KHP04/KH2P04 (pH 8), 0.1 ml of 0.1 
M NH4C1, 0.1 ml of 0.001 M B6 (pyridoxal-6-phosphate) , 0.2 
ml of 0.2 M Thr., 0.1 ml of 0.1 M L-isoleucine, diluted 
with dH20 to 0.9 ml. Then 0.1 ml of the cell extract was 
added to the reaction mixture. After the addition of the 
cell extract, the reaction mixture was incubated for 20 
min at 37°C. The reaction was stopped by the addition of 
0.1 ml of 50% TCA. Three ml of 0.025% 2,4 DNPH (prepared 
in 2 N HC1) was added to the reaction mixture, followed 
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by a 15 min incubation at 25°C. After this incubation, 1 
ml of 40% NaOH was added and the resultant color was 
measured at 540 nm. 
Acetohydroxy acid synthase: The acetohydroxy acid 
synthase assay was carried out according to the methods 
of Stormer and Umbarger (1964). The reaction mixture 
contained 0.1 ml of 1 M KHP04/KH2P04 (pH 8), 0.1 ml of 0.1 
M MgCl2, 0.1 ml of 0.001 M TPP, 0.1 ml of 500 /tg/ml FAD, 
0.2 ml of 0.2 M pyruvate., and 0.1 ml of 0.001 M L-valine, 
diluted to 0.9 ml of dH20. Then 0.1 ml of the cell 
extract was added to the reaction mixture to equal 1 ml. 
Following the addition of the extract, the mixture was 
incubated for 20 min at 37°C and stopped by the addition 
of 0.1 ml of H2S04. After the addition of 1 ml of 0.5% 
creatine hydrate and 1 ml of 5% a-naphthol, the reaction 
mixture was incubated for 1 h at room temperature with 
occasional shaking. The color development was measured 
at 540 nm. The specific activities of both threonine 
deaminase and acetohydroxy acid synthase were expressed 
as /mole of product formed per h per mg protein. 
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Differential Rate of Threonine Deaminase Synthesis 
For determination of the differential rate of 
threonine deaminase synthesis, the procedure of Williams 
and Neidhart (1969) was followed. Plasmid-containing 
cells were grown in minimal-glucose medium for 6 h. Other 
growth conditions included minimal-glucose supplemented 
with isoleucine, leucine, and valine and minimal-glucose 
with cAMP (0.2 mM) . After each hour of growth, the A420 ^ 
and the specific activity of threonine deaminase was 
determined for each sample. The data was plotted as units 
of threonine deaminase per ml (specific activity X A420 nJ 
versus cell density (A420 . 
Branched-Chain Aminoacvl-tRNA Synthetase Assay 
Branched-chain amino acyl-tRNA synthetase: The 
branched-chain aminoacyl-tRNA synthetase assay of 
Chrispeels et al. (1968) was followed. The contents of 
the reaction mixture were 0.1 ml of 2 ng cell extract, 0.1 
ml of Tris-HCl buffer pH 7.3 containing 0.1 M MgCl2 and 
0.1 M KC1, 0.1 ml of 0.1 M GSH (pH 7), 0.1 ml of 0.02 M 
ATP (pH 6.8), 0.1 ml of 10 mg/ml tRNA, 0.1 ml of [14C] 
isoleucine, valine or leucine and diluted with dH20 to 
equal a final volume of 1 ml. The mixture was incubated 
at 37°C for 5 min, stopped by the addition of 3 ml of 5% 
TCA, and precipitated overnight at 5°C. The precipitated 
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tRNA was collected on glass-fiber filters (Fisher 
Scientific) and washed 3 times (twice in 5% TCA and once 
in 67% ethanol) . The filters were allowed to dry and the 
amount of [14C] amino acid attachment was measured in a 
Packard scintillation counter. Reactions were carried out 
in duplicate and one unit of activity was equal to 1 /mole 
of product formed. 
Radiolabel Uptake 
The radiolabel uptake experiment was performed on 
early log phase cells grown in minimal-glucose medium. 
Ten ml samples were collected every 30 min. These samples 
were divided, whereby 5 ml were treated with 50% TCA and 
placed on ice for 1 h and the remaining 5 ml was held at 
25°C for 1 h. Both fractions were then filtered on glass- 
fiber filters (Fisher Scientific). The filters were 
allowed to dry and placed in scintillation cocktail. The 
amount of [3H] isoleucine was measured in Packard 
scintillation counter. 
Isolation of Spontaneous Derivatives 
Plates containing leucine (50 /xg/ml), valine (100 
jug/ml) or leucine (50 /ig/ml) and valine (100 jug/ml) were 
spread with 0.1 ml of late log phase cells of strain 
PS1150 (leus) . After 2 to 3 days of incubation at 37°C, 
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the plates contained resistant colonies. Individual 
resistant colonies were randomly selected and used in this 
study. 
Genetic Mapping of Resistant Genes 
Methods of Rosner (1972) were employed for PI phage 
transduction studies. Ten ml of L-broth containing 
glucose were inoculated with 0.2 ml overnight culture of 
PI phage lysogen. Following the inoculation, the lysogen 
was allowed to grow to an OD550 ^ of 0.5 and then induced 
by UV for 1 min and incubation continued for 3 additional 
h. Following the addition of 0.5 ml of chloroform, the 
suspension was centrifuged and the PI particles were 
collected in the supernatant. To 0.1 ml of each of the 
derivatives (PS1151, leuR; PS1152, valR; and PS1153 
leuR/valR) , 0.1 ml of the phage lysate and 0.1 ml of 0.1 
CaCl2 were added. Equal volumes of L-top agar (2 g 
tryptone, 1 g of yeast extract, 1 g of NaCl and 1.2 g agar 
per liter) and phage lysate mixture were poured onto L- 
agar plates (1 g tryptone, 0.5 g yeast extract, 0.5 g NaCl 
and 1.5 g agar per liter) and incubated at 37°C until 
lysis occurred (6-8 h) . The top agar was removed and 
treated with CHC13. The treated lysate was centrifuged at 
5K rpm for 5 min. Crosses were performed using recipient 
strains carrying markers that map at 2 min (JA200/leu') , 
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85 min (PS1150/leus) , 85 min (CU406/ilvAl) , and 28 min 
(JA200/Trp‘) on the E. coli K-12 chromosome. When using 
PS1150 as the recipient strain, the threonine deaminase 
lysed-cell assay of Blatt et al. (1978) was employed to 
determine whether the ilvA and leuR genes were linked. 
Transductants were grown in minimal-glucose (0.2%) 
overnight. The following day 0.1 ml of 50% glucose was 
added and growth continued for an additional 3-4 h. Cells 
were centrifuged and the pellet was resuspended in 0.3 ml 
of 0.1 M Tris-HCl, pH 8 with 0.15 mM L-isoleucine 
containing 0.035% CETAB. Each suspension was divided into 
0.1 ml fractions. The assay was carried out in a volume 
of 8 ml and the reaction mixture contained 1 ml of Tris- 
HCl, pH 8, 1 ml of 1 M NH4C1, 1 ml of 1 mM B6, 2 ml of 0.2 
M Thr., 1 ml of 0.01 M l-isoleucine, diluted with dH20 to 
8 ml volume. The reaction mixture was incubated for 20 
min at 37°C. The reaction was stopped by the addition of 
0.1 ml of 50% TCA followed by the addition of 3 ml of 
0.025% DNPH. After the 15 min incubation period, 1 ml of 
40% KOH was added to each tube and the resultant color was 
measured at 540 nm. 
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Plasmid DNA Isolation and Purification 
Plasmid DNA was isolated according to the methods of 
Birnboim et al. (1979) , followed by centrifugation in 
ethidium bromide-CsCl gradients (Maniatis et al., 1982). 
Cells were grown in 500 ml of L-broth containing 50 /xg/ml 
ampicillin to mid-log phase. After growth to mid-log 
phase, chloramphenicol (170 /xg/ml) was added and 
incubation continued overnight. The following day, cells 
were centrifuged for 15 min at 6 K rpm. The pellet was 
resuspended in 10 ml of glucose buffer (50 mM glucose, 25 
mM Tris-HCl, pH 7.5, 10 mM EDTA and 20 mg/ml lysozyme). 
After a 5 min period of incubation at 25°C, 20 ml of SDS- 
NaOH solution (1 % SDS and 0.2 M NaOH) were added and 
samples were placed on ice immediately. These samples 
were maintained on ice for 5 min and then 15 ml of 
potassium acetate solution (0.6 M potassium acetate and 
glacial acetic acid) were added. The contents were gently 
mixed by inversion and maintained on ice for 15 min. 
Following the 15 min incubation, the samples were 
centrifuged at 7 K rpm for 15 min. The supernatant was 
removed and transferred to other centrifuge tubes. Fifty 
ml of phenol-chloroform-isoamyl solution (25 parts phenol, 
24 parts chloroform and 1 part isoamyl alcohol) were added 
and the solution was mixed well. After mixing, the sample 
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was centrifuged at 6 K rpm for 5 min. The upper layer was 
removed and transferred to other centrifuge tubes. 
Plasmid DNA was precipitated with 0.6 volume of 
isopropanol. The pellet was collected by 
centrifugation and resuspended in 10 ml of TE buffer, pH 
7.5 (10 mM Tris-HCl and 1 mM EDTA). To the TE buffer 
solution, 10g of CsCl and 0.8 ml of EtBr were added and 
transferred to Ti-65 ultracentrifuge tubes. The 
suspension was centrifuged for 36 h at 15°C at 45 K rpm. 
After the centrifugation, EtBr was removed by 3 NaCl- 
saturated isopropanol extractions and then dialyzed in TE 
buffer overnight. The plasmid DNA was precipitated with 
95% ETOH and 3 M NaAc, pH 4.8 at 20°C. The DNA was washed 
3 times with 70% ETOH and the pellet dried in a speed vac 
concentrator (Savant). The dried pellet was resuspended 
in 150 /ni of TE buffer. 
Restriction Enzyme Digestion of Plasmid DNA 
Plasmid DNA was subjected to restriction endonuclease 
digestion. The reaction mixture contained 5 /xl of the 
appropriate buffer, 10 /xl of plasmid DNA, 2 jxl of the 
appropriate enzyme, and diluted with dHz0 to equal 50 /xl. 
The mixture was incubated at 37°C overnight. Following 
the incubation, the mixture was concentrated in a speed 
vac for 15 min and then subjected to agarose gel 
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electrophoresis (1.5%) in Tris acetate buffer, pH 7.8 (40 
iaM Trizma base, 20 mM NaAc and 2 mM EDTA) containing 0.5 
/ig/ml EtBr. Following electrophoresis, the gel was 
visualized by UV illumination. 
Construction of Subclones 
Plasmid DNA containing the leuR gene fragment was 
digested with the restriction enzyme Sau3A. The largest 
fragment (1.5 Kb) was removed from the gel and placed in 
a dialysis bag along with 10 ml of TE buffer and 1 /il of 
10mg/ml tRNA, and electrophoresed for 1 h at 100 V. After 
1 h, the electrodes were switched and electrophoresis 
continued for 1 min. The fragment was precipitated with 
95% ETOH and 3 M NaAc at -20°C overnight. Following 
precipitation, the fragment was resuspended in 10 /il of 
TE buffer, and then digested with AccI overnight. The 
digestion with AccI generated 0.7 and 0.8 Kb fragments 
with cohesive ends. A blunt-end ligation reaction was 
carried out on both fragments and on the vector, pBR322, 
digested with Clal. The reaction mixture contained 10 /il 
of 0.1 /ig//il restriction fragment, 2 /il of 10X DNA pol I 
buffer, 1 /il of 2 mM dNTP's, and diluted with dH20 to 
equal 25 /il. Two units of Klenow fragment of DNA pol I 
were added and incubated for 30 min at 22°C. Following 
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incubation, the samples were heated to 70°C for 5 min. 
The mixture was extracted once with phenol/chloroform and 
the vector along with the fragment was precipitated with 
95% ETOH. The pellet was dried in a speed vac. After 
drying, the pellet was resuspended in 10 /il of TE buffer. 
The ligation mixture contained 10 /il of DNA, 2 /il of 10X 
T4 ligase buffer, 2 /il of 10 mM ATP, and diluted with dH20 
to a final volume of 2 0 /il. and incubation continued 
overnight at 16°C. One /il of 0.5 M EDTA was added and the 
sample was extracted once with phenol/chloroform. The DNA 
was precipitated with 95% ETOH and 3 M NaAC overnight at - 
20°C. The precipitated DNA was resuspended in 50 /il of TE 
buffer. Following resuspension, the DNA was used to 
transform competent cells of PS1150 and CU406. 
Plasmid DNA from pRL258 of Lawther (1987) containing 
ilvA* gene (Figure 4), was digested with EcoRI and Sail. 
Two fragments were generated, 3.0 and 0.8 Kb. The 0.8 Kb 
was electroeluted as described previously and ligated into 
the EcoRI and Sail sites on pBR322. Following ligation, 
the DNA was used to transform competent cells of CU406. 
Analysis of Plasmid Encoded Proteins 
Methods of Sancar et al. (1979) were employed in this 
protocol. Cells (CSR603, CSR603/pBR322, CSR603/pAW589, 
and CSR603/pAW592) were grown to mid-log phase in 10 ml 
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of K-medium. These cells were placed in a petri dish 
containing a magnetic stirrer and irradiated for 5 min. 
Following irradiation, the cells were placed in 125 ml 
erlenmeyer flasks and incubated for 1 h at 37°C. One- 
tenth ml of 200 /zg/ml of cycloserine was added to the 
culture and incubation continued at 37°C for 12 h. Cells 
were centrifuged at 10 K rpm for 10 min, washed with 
Hershey salts twice, and resuspended in 5 ml Hershey 
medium. Incubation continued for 1 h with aeration, 
followed by the addition of [35S] methionine (5 /iCi/ml) , 
and incubation continued for an additional hour. The 
cells were harvested by centrifugation, lysed, and placed 
on a 5-10% gradient SDS-PAGE gel. After electrophoresis, 
the gel was dried and exposed to X-ray film. 
Nick-Translation and Southern-Blot Hybridization 
Methods of Rigby et al. (1977) and Southern (1975) 
were employed. Plasmid pRL258 was digested with 
restriction enzymes Sail and EcoRI. The 0.8 Kb fragment 
was electro- eluted, precipitated with 95% ETOH, and 
resuspended in 10 /il of TE buffer. The nick-translation 
reaction contained 10 /il DNA, 5 /il of a solution of dGTP, 
dCTP and dTTP, 2.5 /il of 0.4 mM Biotin-14-dATP, and 
diluted with dH20 to equal 45 /il. Five /il of DNA Pol I 
and DNA Pol I/DNase I was added and incubated for 90 min 
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at 15°C. After the incubation, 5 /il of 0.5 M EDTA and 
1.25 /il of 5% SDS were added. The biotinylated DNA was 
precipitated with 95% ETOH and resuspended in 20 /il of TE 
buffer. 
Plasmid DNAs were digested with restriction enzymes 
and subjected to electrophoresis on a 1.5% agarose gel. 
Following electrophoresis, the gel was photographed and 
transferred to nitrocellulose membrane using the semi-dry 
electroblotting apparatus, Sartoblot of Sartorius. 
Following the electroblotting, the membrane was dried 
for 2 h at 80°C under vacuum. During that period, the 
salmon testes DNA was denatured by heating for 10 min in 
a boiling water bath followed by cooling on ice. The 
membrane was gently placed in the hybridization bag 
containing prehybridization solution (50% formamide, 5X 
SSC, 5X Denhardt's solution, 25 mM NaP04, and 0.5 mg/ml of 
denatured salmon testes DNA) and incubated for 4 h at 
42°C. After the incubation period, the prehybridization 
solution was removed; the hybridization solution (45% 
formamide, 5X SSC, IX Denhardt's solution, 20 mM NaP04 pH- 
6.5, 0.2 mg/ml of freshly denatured salmon testes DNA, 
5% dextran sulfate, and 200 ng/ml of freshly denatured 
probe DNA) was added to the hybridization bag and 
incubation continued overnight at 42°C. Following the 
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overnight incubation, the membrane was washed in three 
different concentrations of SSC (2X SSC/0.1% SDS, 0.2X 
SSC/0.1% SDS, and 0.16X SSC/0.1% SDS). After the final 
post-hybridization wash, the BluGENE nonradioactive 
nucleic acid detection system was utilized. The membrane 
was incubated in buffer 2 (0.1 M Tris-HCl (pH 7.5), 0.15 
M NaCl, and 3% bovine serum albumin) for 1 h at 65°C. The 
membrane was thoroughly rehydrated in buffer 2 for 10 min. 
Buffer 2 was removed and SA-AP conjugate, diluted in 
buffer 1 (0.1 M Tris-HCl and 0.15 M NaCl) was added. 
Incubation continued for 10 min at 25°C. After the 
incubation, the membrane was washed three times [twice in 
buffer 1 and once in buffer 3 (0.1 M Tris-HCl pH 9.5, 0.1 
M NaCl, and 0.1 M MgCl2) ]. For visualization, NBT and 
BCIP were diluted in buffer 3. The membrane was incubated 
in the solution for 1.5 h in the dark. After the color 
development, the membrane was washed in 20 mM Tris (pH 
7.5)/0.5 mM EDTA to terminate the color development and 
dried for 5 min at 80°C under vacuum. The nitrocellulose 
membrane was photographed. 
CHAPTER IV 
EXPERIMENTAL RESULTS 
Molecular Cloning of Leur and ilvA* DNA Fragments 
Combined methods of Maniatis et al. (1982) and 
Birnboim et al. (1979) were used to isolate plasmid DNA. 
The leuR recombinant plasmid (pAW589) was constructed by 
the insertion of a wild type (PS1079) Sau3A fragment into 
the BamHI digested pBR322. An array of recombinant 
plasmids were obtained via T4 ligation. An aliquot of 
leuR recombinant plasmid DNA was used to transform the 
mutant strain PS1150 (leus) to leuR. Several Apr colonies 
were subcultured onto nutrient agar plates supplemented 
with ampicillin (50 jug/ml) . Approximately 90% of the Apr 
colonies were tetracycline sensitive (Tcs) . These Apr and 
Tcs colonies were isolated and subcultured onto minimal 
glucose plates supplemented with leucine (50 /xg/ml) . 
Plasmid DNA was isolated from Apr/ Tcs / Leur transformants 
and used to transform a CU406 (ilvA~) (Figure 2) . Plasmid 
(pAW591) ilvA recombinant plasmid was constructed by the 
insertion of wild type Hindlll digested genomic DNA into 
the Hindlll restriction site on pBR322. An aliquot of the 
ilvA recombinant plasmid DNA was used to transform CU406 
(ilvA~) competent cells. Several Apr/Tcr colonies were 
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Figure 2. Construction of recombinant plasmid pAW589 
(Leur) . Genomic DNA of E. coli K-12 strain 
(PS1079) was digested with Sau3A and plasmid 
pBR322 was digested with BamHI. Ligation was 
carried out using T4 DNA ligase. An aliquot 
of the ligation mixture was used to transform 
PS1150 (leus) . ApR/Tcs/leuR transformants 
were selected and used in this study. 
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Construction of Rocombinant Plasmid pAW589 (lauR) 
I Digest 
Bam HI 




Transform PS 1150 Cells (leu8, il» A538) 
Select Colonies Ampr, Tetsand leuR 
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isolated and tested for threonine deaminase activity ( ilvA 
gene product) (Figure 3). Plasmid DNA was isolated from 
ApR/ilvA* transformants and used to transform mutant 
strain, PS1150. Plasmid pBR322 DNA was used as a control. 
The pRL258 of Lawther (1987) was constructed by the 
cloning of the genomic Xhol/Bqlll fragment into pUC9 
vector digested with Sail and BamHI. After ligation, the 
recombinant plasmid was used to transformed "competent" 
CU406 cells and tested for threonine deaminase activity 
(Figure 4). 
Growth of Leur and ilvA* Clones 
To determine the growth characteristics of these 
clones, the growth rate was measured under the conditions 
of minimal-glucose medium supplemented with leucine (50 
/ig/ml) , valine (100 /xg/ml) , and with both leucine (50 
/Ltg/ml) and valine (100 /xg/ml) (Figures 6-8) . As a control 
both strains were grown in minimal-glucose medium (Figure 
5) . Both AU589 and AU591, including PS1079 and mutant 
strain, PS1150, grew at comparable rates in minimal- 
glucose medium. However, upon leucine supplementation, 
AU589 and AU591 exhibited increased growth, but growth was 
inhibited in the mutant strain (PS1150) which is 
consistent with previous studies (Levinthal et al..1973 
and Levinthal et al.. 1976). The wild type, mutant, and 
ilvA538 transformant of pBR322 showed the expected growth 
Figure 3. Construction of recombinant plasmid pAW592 
(putative ilvA*) . Genomic DNA of wild type 
strain (PS1079) was digested with Hindlll and 
plasmid pBR322 was digested with Hindlll. 
Ligation was carried out using T4 ligase. An 
aliquot of the ligation mixture was used to 
transform "competent” CU406 cells. Apr/Tcr 
transformants were selected and tested for 
threonine deaminase activity. The positive 
colonies were used in this study. 
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Construction of Recombinant Plasmid pAW592 (IlvA*) 
Ligate via T4 Ligase 
Transform CU406 Cells (ilv A454) 
Select Colonies Ampr, Tetr and ilvA* 
Figure 4. Construction of recombinant plasmid pRL258 
(ilvA^) . Wild type genomic DNA was digested 
with restriction enzymes Xhol and BollI and 
plasmid pUC9 was digested with Sail and 
BamHI. Ligation was carried out and the 
ligation mixture was used to transform 
"competent" CU406 cells. Apr transformants 
were selected and tested for threonine 
deaminase activity. 
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Construction of Recombinant Plasmid pRL258 (llvDA::Y) 
lac pro 
lac pro 
Transform CU406 Calls (ilv A454) 
Figure. 5. Growth of clones in minimal-glucose medium. 
Cells were grown overnight in minimal-glucose 
medium, inoculated into fresh minimal-glucose 
medium, and incubated with aeration at 37°C. 
Growth was measured at A420 ^ at indicated 
times. Symbols represents strains: 













Figure 6. Growth of clones in minimal-glucose medium 
supplemented with leucine (50 . Cells 
were grown overnight in minimal-glucose 
medium, inoculated into fresh minimal-glucose 
medium, and incubated with aeration at 37°C. 
Growth was measured at A420 m at indicated 
times. Leucine (50 jug/ml) was added as 
indicated by the arrow. Symbols represents 





  AU591 
Figure 7. Growth of clones in minimal-glucose 
medium supplemented with valine (100 
/zg/ml) . Cells were grown overnight in 
minimal-glucose medium, inoculated into 
fresh minimal-glucose medium, and 
incubated with aeration at 37°C. Growth 
was measured at A420 ^ at indicated 
times. Valine (100 fMg/ml) was added as 
indicated by arrow. Symbols : PS1079 

















Figure 8. Growth of clones in minimal-glucose medium 
supplemented with both leucine (50 jug/ml) and 
valine (100 /zg/ml) . Cells were grown 
overnight in minimal-glucose medium, 
inoculated into fresh minimal-glucose medium, 
and incubated with aeration at 37°C. Growth 
was measured at A420 ^ after each hour of 
growth. Leucine (50 /jg/ml) and valine (100 
/xg/ml) were added as indicated by arrow. 
Symbols represents strains: PS1150 ( + ) , AU589 










inhibition in the presence of valine; unexpectedly, the 
ilvA538 clones continued to grow at comparable rates. 
Further, these clones exhibited increased growth in 
minimal-glucose supplemented with both valine and leucine 
as compared to the mutant strain and mutant strain 
carrying pBR322. These data indicated that both clones 
acquired leucine and valine resistant growth phenotypes 
and the recombinant plasmids may be responsible for these 
resistant phenotypes. 
Levels of Isoleucine and Valine Biosynthetic Enzymes 
Tables 2a and 2b present the activities of threonine 
deaminase and acetohydroxy acid synthase of strains grown 
in minimal-glucose medium. The levels of threonine 
deaminase were substantially higher in both types of 
clones (AU589 and AU591) and AU593 (pRL258/PS1150) of 
Lawther as compared to the activities in the ilvA538 
mutant strain (leus) , wild type, as well as the ilvA538 
mutant strain carrying pBR322. Similarly, the leuR, the 
ilvAl, and the ilvA+ (Lawther, 1987) transformants of the 
ilvA454 mutant strain (CU406) exhibited increased levels 
of threonine deaminase activity as compared to the levels 
in the ilvA454 mutant strain and the ilvA454 mutant strain 
carrying pBR322. Consistent with the ilvA538/leuR clone, 
the i1vA538/i1vA* clone also exhibited increased growth in 
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Table 2a 
Levels of Isoleucine and Valine Biosynthetic Enzymes 
♦Specific Activities 
Strains Growth Threonine Acetohydroxy 
Conditions Deaminase Acid Synthase 
PS1079 
( ilvA+} 
MG 0.73 0.24 
PS1150 
(ilvA538} 
MG 0.02 0.16 
AU322 
(ilvA538/oBR322} 
MG 0.04 0.19 
AU589 
( ilvA538/leuR} 
MG 1.56 0.13 
AU591 
( ilvA538/ilvA+} 
MG 1.29 0.34 
AU593 
( ilvA538/ilvA+) 
MG 1.30 0.16 
♦Specific activities are expressed as /moles of 
product/h/mg protein. 
MG - Minimal-glucose medium 
Mean represents three independent experiments. 
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Table 2b 










MG 0.76 0.14 
CU406 
( ÜVA454} 
MG + iso. 0.00 0.06 
AU323 
( ÜVA454/DBR322^ 
MG + iso. 0.05 0.02 
AU590 
( ilvA454/leuR} 
MG 1.05 0.23 
AU592 
( ilvA454/ilvA+) 
MG 1.04 0.11 
AU594 
( ilvA454/ilvA+) 
MG 0.59 0.08 
♦Specific activities are expressed as /moles of 
product/h/mg protein. 
MG - Minimal-glucose medium 
MG + iso. - Minimal-glucose medium supplemented with 
isoleucine (50 ng/ml) . 
Mean represents three independent experiments. 
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minimal-glucose medium plus leucine and valine (Figure 8) 
and the ilvA454/leuR exhibited increased levels of TD 
activity along with a valR growth phenotype. From these 
these observations, it is suggested that these recombinant 
plasmids may contain DNA fragments with similar nucleotide 
sequences. 
However, acetohydroxy acid synthase activities 
appeared to be higher in the ilvA* clone and somewhat 
reduced in the leuR clone when compared to the wild type 
and the other ilvA538 strains. In the leuR and ilvA* 
transformants of the ilvA454 mutant strain, acetohydroxy 
acid synthase activity was increased when compared to the 
ilvA454 mutant strain. 
Differential Rate of Synthesis of Threonine Deaminase 
Differential rate of threonine deaminase synthesis 
in plasmid-containing strains is shown in Figure 9. To 
determine whether the elevated levels of TD activity were 
indeed due to new synthesis or to the activition of pre¬ 
existing enzyme, the differential rate experiment was 
carried out on ilvA454 transformants. The synthesis of 
TD in the leuR and ilvA* clones was increased as compared 
to the pBR322 transformant, which is consistant with the 
activities shown in Table 2b. Further, the differential 
rate plot displayed a continuous increase in TD synthesis 
Figure 9. Differential rate of threonine deaminase 
synthesis in E. coli clones. These 
transformed cells were grown in minimal- 
glucose medium for 6 h. After each hour of 
growth, the A420 ^ and the specific activity 
of threonine deaminase was determined for 
each sample. The data were plotted as units 
of threonine deaminase per ml (specific 
activity X A420 versus cell density 
























Differential Rate of TD Synthesis 
Cell Density (A420 nm) 
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in the clones relative to the pBR322 transformant. These 
findings suggest that the elevated levels of TD synthesis 
were due to new synthesis. 
Levels of Isoleucvl- and Valvl-tRNA Synthetases 
The activities of isoleucyl- and valyl-tRNA 
synthetases are presented in Table 3. The levels of 
isoleucyl-tRNA synthetase were higher in the ilvA538 
clones than in the pBR322 transformant of the ilvA538 
mutant strain. As mentioned previously, the levels of 
isoleucyl-tRNA synthetase activity were lower in the 
ilvA538 mutant than in the wild type. In the ilvA454 
strains, the activities of isoleucyl-tRNA synthetase were 
higher in the ilvA454 clones than in the pBR322 
transformant of the ilvA454 mutant strain and in the 
ilvA454 mutant strain. Further, valyl-tRNA synthetase 
activity was lower in the ilvA538 mutant strain and in 
the pBR322 transformant of the ilvA538 strain as compared 
to the ilvA538 clones. The activities of valyl-tRNA 
synthetase were increased in both the leuR and ilvA* 
transformants of ilvA454 mutant strain as compared to the 
activities in the other ilvA454 strains. 
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Table 3 










MG 0.25 0.52 
PS1150 
(ilvA538) 






MG 0.65 0.47 




MG 0.15 0.28 
CU406 
(ilvA454) 
MG + iso. 0.09 0.05 
AU323 
(ilvA454/oBR322ï 
MG + iso. 0.09 0.05 
AU590 
( ilvA54/leuR} 
MG 0.59 0.49 
AU592 MG 0.31 0.37 
( ilvA454/ilvA*^ 
 *Specific activities are expressed as /xmoles 
product/h/mg protein. 
MG - Minimal-glucose medium 
MG + iso. - Minimal-glucose medium plus isoleucine 
(50 Mg/mi) 
Mean represents three independent experiments. 
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Incorporation of Isoleucine into cells 
The isoleucine uptake experiment was performed to 
determine whether isoleucine was incorporated into 
plasmid-containing cells during normal growth (Figure 10 
and 11). Isoleucine incorporation was determined over a 
period of 150 min by measuring the amount of [3H] 
isoleucine in the soluble and insoluble fractions (total 
incorporation) and [3H] isoleucine in the insoluble 
fraction (TCA precipitated). In Figure 10, total [3H] 
isoleucine uptake was determined and initial incorporation 
occurred at about 30 min in all strains, but initial 
incorporation was higher in the wild type and the mutant 
than in the strains carrying plasmids. When assessing the 
[3H] isoleucine that was incorporated into proteins (TCA 
insoluble), uptake occurred in all the strains, but again 
the amount of [3H] isoleucine incorporated into protein 
was lowerin the strains harboring plasmids. These data 
show that [3H] isoleucine was incorporated into these 
cells under normal growth conditions, but incorporation 
was reduced in the plasmid-containing cells. 
Figure 10. Total [3H] isoleucine uptake in bacterial 
strains. Cells were grown to early log phase 
in minimal-glucose medium. Five ml samples 
were collected every 30 min for 2.5 h. 
Samples were held at 25°C for 1 h. Then 
these samples were filtered and the amount 
of [3H] isoleucine was measured via 
scintillation counting. Symbols represents 
strains: PS1079 (*), PS1150 (+), AU322 (0), 



















Figure 11. [3H] isoleucine TCA insoluble uptake in 
bacterial strains. Cells were grown to early 
log phase in minimal-glucose medium. Five 
ml samples were collected every 30 min for 
2.5 h. Samples were treated with 50% TCA and 
placed on ice for 1 h. Then samples were 
filtered and the amount of [3H] isoleucine was 
measured via scintillation counting. Symbols 
represents strains: PS1079 (*), PS1150 (+), 
AU322 (0), AU589 (#),AU591 (.). 
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Effects of Isoleucine and Valine Separately on Threonine 
Deaminase and Acetohvdroxv Acid Synthase Activities 
To determine the effect of isoleucine or valine upon 
threonine deaminase and acetohydroxy acid synthase 
activities, cells were grown in minimal-glucose medium, 
then either isoleucine or valine was added to the growth 
medium and growth continued until cells reached late log 
phase. Table 4 shows the activities of threonine 
deaminase and acetohydroxy acid synthase. In the presence 
of isoleucine (50 jug/ml) , threonine deaminase activity was 
derepressed in all strains, except in both wild types CU4 
and PS1079, which showed a repressed effect. Furthermore, 
valine derepressed threonine deaminase activity in both 
wild types, but varying effects were observed in both 
classes of clones. Isoleucine had a derepressed effect 
on acetohydroxy acid synthase in all strains, except in 
CU406 mutant. Valine had the same derepresed effect on 
all the strains, except for leuR (AU589 and AU590) and 
ilvA* (AU591) clones, which showed no effect. 
Effects of Isoleucine and Valine Separately on the 
Branched-Chain Aminoacvl-tRNA Synthetases 
The activities of the branched-chain aminoacyl-tRNA 
synthetases are presented in Table 5. In the presence of 
isoleucine, isoleucyl-tRNA synthetase was repressed in 
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Table 4 
Effects of Isoleucine and Valine Separately on Threonine 








PS1079 MG 0.70 0.05 
MG + iso. 0.63 0.07 
MG + val. 0.92 0.09 
PS1150 MG 0.04 0.05 
MG + iso. 0.15 0.20 
MG + val. 0.26 0.12 
AU589 MG 1.02 0.10 
MG + iso. 3.85 0.57 
MG + val. 1.46 0.11 
AU591 MG 0.46 0.12 
MG + iso. 3.39 0.18 
MG + val. 1.12 0.12 
CU4 MG 0.68 0.04 
MG + iso. 0.59 0.08 
MG + val. 0.71 0.15 
CU406 MG 0.00 0.12 
MG + iso. 0.09 0.05 
MG + val. 0.12 0.16 
AU590 MG 1.50 0.09 
MG + iso. 1.17 0.15 
MG + val. 1.34 0.10 
AU592 MG 0.52 0.15 
MG + iso. 2.17 0.19 
MG + val. 0.40 0.18 
* Specific activities are expressed as /mole 
product/h/mg protein. 
MG - Minimal-glucose medium 
MG + iso. - Minimal-glucose medium plus isoleucine (50 
Mg/ml) 
MG + val. - Minimal-glucose medium plus valine (100 /xg/ml) 
Mean represents three independent experiments. 
66 
Table 5 
Effects of Isoleucine and Valine Separately on the 
Branched- Chain Aminoacyl-tRNA Synthetases 
♦Specific Activities 
Strains Growth Isoleucyl-tRNA Leucyl-tRNA Valyl-tRNA 
Conditions Synthetase Synthetase Synthetase 
PS1079 MG 0.25 0.19 0.51 
MG + iso. 0.19 0.12 1.08 
MG + val. 0.01 0.11 0.62 
PS1150 MG 0.12 0.15 0.15 
MG + iso. 0.30 0.14 1.08 
MG + val. 0.32 0.14 0.67 
AU589 MG 1.00 0.18 0.83 
MG + iso. 1.00 0.20 0.72 
MG + val. 0.55 0.14 0.82 
AU591 MG 0.60 0.18 0.78 
MG + iso. 0.50 0.20 1.08 
MG + val. 0.78 0.12 0.53 
CU4 MG 0.31 0.16 1.12 
MG + iso. 0.33 0.15 0.52 
MG + val. 0.47 0.17 0.79 
CU406 MG 0.10 0.14 0.82 
MG + iso. 0.26 0.14 0.49 
MG + val. 0.43 0.15 0.65 
AU590 MG 0.30 0.23 0.88 
MG + iso. 0.37 0.12 0.73 
MG + val. 0.27 0.14 0.56 
AU592 MG 0.32 0.17 0.67 
MG + iso. 0.31 0.14 0.05 
MG + val. 0.37 0.14 0.73 
* Specific activities are expressed as jumoles 
product/h/mg protein. 
MG - Minimal-glucose medium 
MG + iso. - Minimal-glucose medium plus isoleucine (50 
Mg/ml) 
MG + val. - Minimal-glucose medium plus valine (100 /ig/ml) 
Mean represents three independent experiments. 
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PS1079 and AU591, but derepressed in PS1150 and AU590, 
whereas isoleucine had no effect on AU589, AU592 and the 
wild type, CU4• Valine had varying effects on both wild 
types and mutants, but valine had a repressed and 
derepressed effect on both classes of leuR and ilvA* 
clones, respectively. Isoleucine had a derepressed effect 
on valyl-tRNA synthetase activity in PS1079 and PS1150, 
but had opposite effects on VRS activity in AU589 
(repressed) and AU591 (derepressed). Isoleucine repressed 
VRS activity in all ilvA454 strains including the wild 
type, CU4. Valine showed a repressed effect in CU4, 
CU406, AU590, but opposite effects were observed in the 
ilvA* clones (AU591, repressed) and (AU592, derepressed), 
whereas no effect was observed in AU589. Leucyl-tRNA 
synthetase activity was repressed in both wild types in 
the presence of isoleucine. Valine had the same effects 
in both classes of clones, repressed in AU589 and AU591 
and repressed in AU590 and AU592. Valine repressed 
leucyl-tRNA synthetase activity in the ilvA538 clones, 
including the wild type, PS1079 and both ilvA454 clones, 
but valine had no effect on the CU4, CU406 and PS1150. 
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Effects of the Branched-Chain Amino Acids on Threonine 
Deaminase Activity 
To determine whether the increased levels of TD 
activity were regulated via the multivalent attenuation 
control signal, cells were grown in minimal-glucose and 
minimal-glucose supplemented with leucine (50 jig/ml) , 
valine (100 jug/ml) and isoleucine (50 /xg/ml) (Table 6) . 
The multivalent attenuation signal was present in the wild 
type but not in the ilvA538 clones, the ilvA538 mutant 
strain nor the pBR322 transformant of ilvA538 strain. 
Unlike the ilvA538 clones, the multivalent attenuation 
signal was present in the ilvA454 clones. These data 
suggest that the ilvA538 mutant may contain another 
mutation since all of the mutant properties were restored 
except the multivalent attenuation control signal. 
Differential Rates of Threonine Deaminase Synthesis in 
Cells Grown under Non-Repressed and Repressed Conditions 
Since TD activity appeared not to be regulated via 
the multivalent attenuation control mechanism in PS1150 
transformants, the differential rate of TD synthesis was 
determine in cells grown under repressed and non-repressed 
conditions (Figure 12) . The differential rate plot showed 
that TD synthesis was continuous and the rate of synthesis 
did not respond to the branched-chain amino acids via the 
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Table 6 
Effects of the Branched-Chain Amino Acids on 
Threonine Deaminase Activity 
Strains Growth Conditions 
♦Specific Activity 
Threonine Deaminase 
PS1079 MG 0.60 
MG + ilv 0.44 
PS1150 MG 0.04 
MG + ilv 0.11 
AU322 MG 0.02 
MG + ilv 0.06 
AU589 MG 0.63 
MG + ilv 0.81 
AU591 MG 0.50 
MG + ilv 0.63 
CU4 MG 1.03 
MG + ilv 0.52 
CU406 MG 0.00 
MG + ilv 0.12 
AU323 MG 0.06 
MG + ilv 0.07 
AU590 MG 1.13 
MG + ilv 0.54 
AU592 MG 0.80 
MG + ilv 0.50 
*Specific activities are expressed as /xmoles 
product/h/ mg protein. 
MG - Minimal-glucose medium 
MG + ilv - Minimal-glucose medium + isoleucine (50 jug/ml) 
+ leucine (50 jug/ml) + valine (100 /zg/ml) . 
Mean represents three independent experiments. 
Figure 12. Differential rates of threonine deaminase 
synthesis in E. coli clones under non- 
repressed and repressed conditions. A: 
represents transformed cells grown in 
minimal-glucose medium and B: represents the 
same cells grown in minimal-glucose medium 
supplemented with excess branched-chain amino 
acids (isoleucine, leucine, valine). 
Symbols: AU322 (A), AU589 (•), AU591 (0). 
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multivalent attenuation control signal. These data 
further substantiates the previous data on TD activity 
that the control signal is non-functional in these ilvA538 
clones, and there is probably another mutation responsible 
for the lack of gene control. 
Differential Rates of Threonine Deaminase Synthesis in 
Cells Grown in the Absence and Presence of cAMP 
This experiment was performed the same as the 
previous experiment except cAMP (0.2 mM) was added to the 
growth medium (Figure 13) . In the presence of cAMP, TD 
synthesis was continuous in both the leuR and in the 
putative ilvA+ clone, but the leuR clone revealed a 
substantial increase in TD synthesis. This increased rate 
was the result of cAMP inhibition of isoleucyl-tRNA 
synthetase which was consistent with previous data of 
Williams and Barnett (1985). Also, Lopes and Lawther 
(1989) reported cAMP binding sites in the internal 
promoter of the ilvA gene; therefore, cAMP may activate 
the PA which may account for the increase in TD activity. 
Figure 13. Differential rates of threonine deaminase 
synthesis in E. coli clones in the absence 
and presence of cAMP. A: represents 
transformed cells grown in minimal-glucose 
medium and B: represents the same cells grown 
in minimal-glucose medium supplemented with 
0.2 mM CAMP. Symbols: AU322 (A), AU589 (•), 
AU591 (0). 
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Effects of the Branched-Chain Amino Acids on Isoleucvl- 
and Valvl-tRNA Synthetases 
The activities of isoleucyl- and valyl-tRNA 
synthetases are shown in Table 7. Under repressing 
conditions, isoleucyl-tRNA synthetase activities were 
lowered in the wild type, ilvA538 mutant and in the 
ilvA538 mutant carrying pBR322. A slight increase in 
activity was observed in both of the ilvA538 clones, 
indicating that the repression mechanism was 
non-functional in these clones. However, the levels of 
valyl-tRNA synthetase were increased in the wild type, but 
a slight decrease was observed in both ilvA538 clones, 
ilvA538 mutant strain and in the pBR322 transformant of 
the ilvA538 mutant, suggesting that valyl-tRNA synthetase 
activity was repressed in the ilvA538 clones. Further, 
isoleucyl- and valyl-tRNA synthetase activities were 
repressed in all the ilvA454 strains except in the ilvA454 
mutant strain. 
Growth Characteristics of Spontaneous Derivatives 
Three types of derivatives were isolated through the 
spontaneous mutagenesis process (e.g. PS1151, leuR; 
PS1152, valR; and PS1153, leuR/valR) . All three 
derivatives grew at comparable rates in minimal-glucose 
medium (Figure 14) and in minimal-glucose medium 
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Table 7 
Effects of the Branched-Chain Amino Acids on Isoleucvl- 









PS1079 MG 0.20 0.50 
MG + ilv 0.05 0.36 
PS1150 MG 0.07 0.37 
MG + ilv 0.04 0.35 
AU322 MG 0.08 0.27 
MG + ilv 0.05 0.24 
AU589 MG 0.15 0.58 
MG + ilv 0.19 0.07 
AU591 MG 0.18 0.62 
MG + ilv 0.19 0.09 
CU4 MG 0.11 0.34 
MG + ilv 0.05 0.04 
CU406 MG 0.01 0.01 
MG + ilv 0.04 0.03 
AU32 3 MG 0.05 0.05 
MG + ilv 0.03 0.04 
AU590 MG 0.14 0.63 
MG + ilv 0.07 0.09 
AU592 MG 0.10 0.32 
MG + ilv 0.05 0.07 
♦Specific activities are expressed as /moles 
product/h/mg protein. 
MG - Minimal-glucose medium 
MG + ilv - Minimal-glucose + isoleucine (50 /xg/ml) + leucine 
(50 /ig/ml) + valine (100 /*g/ml) 
Mean represents three independent experiments. 
Figure 14. Growth of spontaneous derivatives. 
Cells were grown in minimal-glucose 
medium overnight, inoculated into fresh 
minimal-glucose medium, and incubated 
with aeration at 37°C. Growth was 
measured at indicated times. Symbols 
represents strains: PS1079 (*), PS1150 









supplemented with their respective amino acid. The valR 
derivative was sensitive to growth inhibition by leucine 
(50 jug/ml) , suggesting that the ilvA538 allele remained 
intact (Figure 15). Similarly, the leuR derivative was 
sensitive to growth inhibition by valine (100 /ig/ml) 
indicating the presence of the vals phenotype (Figure 16) . 
Activities of Threonine Deaminase and Acetohvdroxv Acid 
Synthase in Spontaneous Derivatives 
Table 8 represents the activities of threonine 
deaminase and acetohydroxy acid synthase of strains grown 
in minimal-glucose medium. Spontaneous derivatives of 
PS1150 were isolated to determine whether the leucine and 
valine resistant growth phenotypes expressed in both 
classes of transformants (PS1150/pAW589/ leuR and 
PS1150/pAW592/ilvA*) could be induced at the chromosomal 
level in the absence of the recombinant plasmids. The 
levels of threonine deaminase were substantially lower in 
the derivatives in comparison to wild type activities. 
Acetohydroxy acid synthase activities were lower in the 
ilvA538 mutant strain, valR derivative, and in the 
valR/leuR derivative, but appeared higher in the wild type 
and in the leuR derivative. 
Figure 15. Growth of spontaneous derivatives in minimal- 
glucose medium with leucine (50 /ig/ml) . 
Cells were grown overnight in minimal-glucose 
medium, inoculated into fresh minimal-glucose 
medium, and incubated with aeration at 37°C. 
Growth was measured at indicated times. 
Leucine (50 jug/ml) was added after 2 h of 
growth. Symbols represents strains: PS1079 
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Figure 16. Growth of spontaneous derivatives in minimal- 
glucose medium with valine (100 /ig/ml) . 
Cells were grown overnight in minimal-glucose 
medium, inoculated into fresh minimal-glucose 
medium, and incubated with aeration at 37°C. 
Growth was measured at A,,n _ after each hour 
of growth. Valine (100 ^ig/ml) was added 
after 2 h of growth. Symbols represents 
strains: PS1079 (*) , PS1150 ( + ) , PS1151 (#) , 
PS1152 (0). 
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Activities of Threonine Deaminase and Acetohvdroxv Acid 
Synthase in Spontaneous Derivatives 
♦Specific Activities 
Strains Growth Threonine Acetohydroxy Acid 
Conditions Deaminase Synthase 
PS1079 MG 0.60 0.23 
PS1150 MG 0.06 0.10 
PS1151 
/ 
MG 0.04 0.20 
PS1152B MG 0.15 0.13 
PS1153 MG 0.10 0.10 
♦Specific activities are expressed as Mmoles 
product/h/mg protein. 
MG - Minimal-glucose medium 
Mean represents three independent experiments. 
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Activities of the Branched-Chain Aminoacvl-tRNA 
Synthetases in Spontaneous Derivatives 
The activities of the three branched-chain arainoacyl- 
tRNA synthetases are presented in Table 9. Isoleucyl-tRNA 
synthetase activities were slightly lower in the three 
derivatives and in the ilvA538 mutant strain as compared 
to the activities in the wild type. The activities of 
leucyl-tRNA synthetase showed slight variations in all 
derivatives. Further, valyl-tRNA synthetase activities 
were higher in the wild type, leuR, valR, leuR/valR 
derivative than in the ilvA538 mutant strain. 
Genetic Mapping of Resistant Genes 
Generalized Plcm transductions were performed by 
procedures of Rosner (69) (Table 10). Recipient strains 
JA200 (Leu' and Trp') , CU406 (ilvAl) , and PS1150 (Leus) 
were used in the crosses with donor strains PS1151 (leuR) , 
PS1152 (valR) and PS1153 (leuR/valR) . Strain JA200 was 
infected with phage grown on PS1152 and on PS1153. The 
Trp+ prototropic transductants were selected from both. 
These transductants were tested for resistance to valine 
and 0% linkage was observed to Trp which is located at 28 
min on the E. coli chromosome (Figure 17) . PS1153 was 
also crossed with recipient strain CU406 and linkage of 
the valR marker to the ilvA gene was not observed. Since 
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Table 9 
Activities of the Branched-Chain Aminoacvl-tRNA 














PS1079 MG 0.22 0.74 0.15 
PS1150 MG 0.04 0.44 0.14 
PS1151 MG 0.02 0.50 0.18 
PS1152B MG 0.04 0.61 0.14 
PS1153 MG 0.02 0.58 0.19 
♦Specific activities are expressed as nmoles 
product/h/mg protein. 
MG - Minimal glucose medium 
Mean represents three independent experiments. 
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Table 10 
Genetic Mapping of Resistant Genes 










JA200 41 0 0 (control) 
PS1152 
(Valr) 
JA200 39 0 0 
PS1153 
(Leur/Valr) 
JA200 37 0 0 








PS1151 JA200 42 - 0 (control) 
PS1152 JA200 40 0 0 











PS1151 CU406 90 - 0 (control) 
PS1152 CU406 41 0 0 
PS1153 CU4 06 9 0 0 
Donor Recipient No. 
Leur 
TD* % Linkage to 
TD Activity 
(CETAB Assay) 
PS1151 PS1150 61 (5) 0 0 
PS1152 PS1150 0 - - (control) 




‘“Generalized (Plcm) transductions were performed by the 
procedures of Rosner (1972). Transductants were selected 
and scored for different characters by replica plating onto 
minimal-glucose agar plates in the presence and absence of 
test metabolite. 
Figure 17. An abbreviated map of the E. coli K-12 
chromosome. The highlighted regions are 
genes represented by the recipient strains 









PS1150 is the only known leus mutant, crosses with PS1151 
the leuR derivative were possible only with the parent 
strain PS1150, since all the other recipient strains would 
be leuR. 
Measurement of Threonine Deaminase Activities in Leucine- 
Resistant Transductants of Strain PS1150 bv CETAB Assay 
The cetyltrimethylammonium bromide (CETAB) assay was 
used to determine TD activity in the leucine-resistant 
transductants (Table 11) . Strain PS1150 was infected with 
phage grown on PS1151 and PS1153; leuR transductants were 
selected. After the initial selection, the transductants 
were checked for their leuR growth phenotype. These leuR 
transductants were tested for TD activity using the CETAB 
assay. The leuR marker of PS1151 (leuR) showed no linkage 
to the ilvA gene, whereas the leuR marker of PS1153 
(leuR/valR) showed 31% linkage to the ilvA gene. 
Surprisingly, these transductants exhibited a valR growth 
phenotype. The three genes expressed by the clones are 
located in the same region of the E. coli K-12 chromosome. 
Agarose Gel Analysis of Recombinant Plasmids 
Plasmid DNA was isolated from both leuR and ilvA* 
recombinant clones and the pBR322 transformant of the 
ilvA538 mutant by methods of Birnboim et al. (1979) with 
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Table 11 
Measurement of Threonine Deaminase Activities in Leucine 
Resistant Transductants of Strain PS1150 bV CETAB Assay 
Strain TD Activity 
PS1150 (leus) 0.184 
PS1153 (leuR) 0.018 
















TD Activity = OD/min/Klett #42/5.0 ml culture (x 1000) 
CETAB = cetyltrimethylammonium bromide (a cationic 
surfactant) 
ND = None Detectable 
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Table 11 (continued) 
Measurement of Threonine Deaminase Activities in Leucine- 
Resistant Transductants of Strain PS1150 bv CETAB Assay 
Strain TD Activity 
#16 0.040 
PS1150 (leuR) 0.184 
PS1151 (leuR) ND 






TD Activity = OD/min/Klett#42/5.0 ml culture (x 1000) 
CETAB = cetylrimethy1ammonium bromide (a cationic 
surfactant) 
ND = None Detectable 
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modifications (Figure 18). After isolation, the plasmid 
DNA was subjected to agarose (0.8%) gel electrophoresis. 
The gels were stained with 0.5 /xg/ml of ethidium bromide 
during electrophoresis. Following electrophoresis, the 
gels were visualized by UV illumination and photographed. 
Several forms of the plasmid DNA were observed, 
representing the relaxed (open circle) and supercoiled 
(covalently closed circle) forms of the plasmids. Based 
upon migration position in agarose gels, it appears that 
the recombinant plasmids can be readily distinguished from 
plasmid pBR322. 
Analysis of Leur and jlvA* DNA Fragments 
Plasmid DNA was isolated from the leuR and ilvA* 
recombinant plasmids. After isolation and purification, 
each plasmid was digested with their respective enzymes 
(leuR/Sau3A. ilvA+/BamHI and Hindlll) . DNA fragments were 
separated on 1.5% horizontal agarose gel. The gel was 
stained with 0.5 /xg/ml of ethidium bromide during 
electrophoresis. Several fragments ranging in sizes of 
1.5 Kb to 0.3 Kb were generated from the leuR/Sau3A 
digestion (Figure 19). Plasmid DNA containing the ilvA* 
gene was double digested with restriction enzymes BamHI 
and Hindlll. Fragments of approximately 3.8 and 0.5 Kbs 
were generated from the ilvA* digestion (Figure 19) . The 
Figure 18. Agarose gel analysis of recombinant plasmids. 
Lane 1: pBR322, lane 2: pAW589 (leuR) , and 
lane 3: pAW591 ( ilvA*) . Plasmid DNAs were 
electrophoresed on a 0.8% agarose gel and 
stained with ethidium bromide (0.5 /ig/ml) . 
DNAs were made visible by UV illumination. 
88 
Figure 19. Agarose gel analysis of plasmid DNAs digested 
with restriction endonucleases. Lane 1: 
pAW589 (leuR)/ Sau3A. lane 2: 1 Kb ladder, 
lane 3: pAW592/ BamHI and Hindlll. Plasmid 
DNAs were electrophoresed on a 1.5% agarose 
gel and stained with ethidium bromide (0.5 




0.5 Kb fragment was electroeluted and purified. After 
purification, the fragments of approximately 0.5 and 1.5 
Kbs were ligated (by corresponding enzymes) into pBR322, 
to determine whether these were the fragments of interest. 
Following ligation the recombinant plasmids were used to 
transform PS1150 and CU406 "competent” cells. 
Growth Characteristics of Second Generation Transformants 
The ilvA538 clones were grown in minimal-glucose 
medium to early log phase. Then either leucine (50 
/ig/ml) or valine (100 /xg/ml) was added to the growth 
medium (Figures 20 and 21) . Both types of clones grew 
at comparable rates upon amino acid supplementation. 
Threonine Deaminase Activity in Second Generation 
Transfomants 
Threonine deaminase activity in second generation 
transformants is shown in Table 12. The fragments of the 
initial clones pAW589 (1.5 Kb) and pAW592 (0.5 Kb) were 
cloned into pBR322. After the cloning, these recombinant 
plasmids were used to transform "competent" PS1150 and 
CU406 cells. Following the transformation and selection, 
these transformants were assayed for threonine deaminase 
activity. Both types of clones pAW589-2/PS1150, pAW589- 
2/CU406, pAW592-2/PS1150, and pAW592-2/CU406 exhibited 
Figure 20. Growth of second generation transformants in 
minimal-glucose medium with leucine (50 
/itg/ml) . Cells were grown overnight in 
minimal-glucose medium inoculated into fresh 
minimal-glucose medium and incubated with 
aeration at 37°C. Growth was measured at 
indicated times. Leucine was added after 2 
h of growth as indicated by the arrow. 
Symbols represent strains: PS1079 (*) , PS1150 
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Figure 21. Growth of second generation transformants in 
minimal-glucose medium with valine (100 
jug/ml) . Cells were grown overnight in 
minimal-glucose medium, inoculated into fresh 
minimal-glucose medium, and incubated with 
aeration at 37°C. Growth was measured at 
indicated times. Valine was added after 2 
h of growth as indicated by the arrow. 
Symbols represent strains: PS1079 (*) , PS1150 

















PS1079 MG 0.73 
PS1150 MG 0.02 
AU322 MG 0.04 
AU589-2 MG 1.88 
AU591-2 MG 0.98 
CU4 MG 0.76 
CU4 06 MG + iso. 0.00 
AU323 MG + iso. 0.01 
AU590-2 MG 1.42 
AU592-2 MG 1.40 
*Specific activities are expressed as jumoles of 
product/h/mg protein. 
MG - Minimal-glucose medium 
MG + iso. - Minimal-glucose medium plus isoleucine 
(50 [iq/ml) 
Mean represents three independent experiments. 
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high levels of threonine deaminase activity as compared 
to ilvA538. ilvA454 mutants, and both mutants carrying 
pBR322. Clones containing recombinant plasmids; the 1.5 
Kb, leuR and 0.5 Kb, UvA* exhibited leuR, valR, and 
increased levels of threonine deaminase activity, which 
were identical to the properties exhibited by the initial 
clones. For further characterization of these recombinant 
plasmids, Southern blot hybridizations were employed using 
plasmid pRL258 ( ilvA*) (Lawther et al., 1987) as the 
probe. Data from these experiments were inconclusive. 
Analysis of Leur DNA Fragment: Subcloninq 
The 1.5 Kb fragment was electroeluted, purified, and 
digested with several restriction enzymes (Sail, BamHI 
Hindlll. and AccI). The AccI digest generated fragments 
of approximately 0.7 and 0.8 Kb (Figure 22). After 
purification, the fragments (0.7 and 0.8 Kb) were ligated 
into the Clal site of pBR322. Following ligation, the 
recombinant plasmids were used to transform PS1150 and 
CU406 "competent cells". 
Figure 22. Agarose gel analysis of subfragments 
generated from the Leur fragment. Lane 1: 1 
Kb ladder and lane 2: fragments (0.7 and 0.8 
Kb). DNA fragments were electrophoresed on 
a 1.5% agarose gel and stained with ethidium 
bromide (0.5 jug/ml) . Fragments were made 
visible by UV illumination. 
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Growth Characteristics and Threonine Deaminase Activity 
in Subclones 
The growth of the subclones is shown in Figures 23 and 
24. Both types of ilvA538 subclones grew at comparable 
rates upon either leucine (50 nq/ml) or valine (100 /xg/ml) 
supplementation. Threonine deaminase activity of the 
subclones are shown in Table 13. In both types of 
subclones (AU589-7, AU589-8, AU590-7, and AU590-8), 
threonine deaminase activity was significantly higher than 
in the ilvA538 and ilvA454 mutants, and in these mutant 
strains carrying pBR322. 
Analysis of Plasmid Encoded Proteins 
For identification of proteins encoded by plasmids 
pBR3 22, PRL258 (ilvAl) (Lawther et al., 1987), pAW592 
( ilvA+) . pAW589 (leuR) , pCH7, and pCH8, the maxicell 
protocol of Sancar et al. (1979) was employed (Figure 25) . 
Protein lysates of pAW589 and pAW592 revealed proteins in 
the 100 KDa range that were not found in pBR322-containing 
lysates, which may represent the dimer form of TD. The 
protein lysate from pRL258, which contains the known ilvA 
gene also revealed proteins in the 100 KDa range. Protein 
lysates from pCH7 and pCH8 revealed different protein 
profiles from that of the leuR and both ilvA* recombinant 
plasmids. Moreover, densitométrie scanning profiles were 
Figure 23. Growth of subclones in minimal-glucose medium 
with leucine (50 jug/ml) . Cells were grown 
overnight in minimal-glucose medium, 
inoculated into fresh minimal-glucose medium, 
and incubated with aeration at 37°C. Growth 
was measured at indicated times. Leucine was 
added after 2 h of growth. Symbols represent 
strains: PS1079 (*), PS1150 (+), AU322 (0), 
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Figure 24. Growth of subclones in minimal-glucose medium 
with valine (100 [ig/m 1) . Cells were grown 
overnight in minimal-glucose medium, 
inoculated into fresh minimal-glucose medium, 
and incubated with aeration at 37°C. Growth 
was measured at indicated times for 6 h. 
Valine was added after 2 h of growth. 
Symbols represent strains: PS1079 (*), 
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PS1079 MG 0.73 
PS1150 MG 0.02 
AU322 MG 0.04 
AU589-7 MG 0.61 
AU589-8 MG 0.86 
CU4 MG 0.76 
CU4 06 MG + iso. 0.00 
AU323 MG + iso. 0.01 
AU590-7 MG 0.23 
AU590-8 MG 0.20 
♦Specific activities are expressed as /nmoles of 
product/h/mg protein. 
MG - Minimal-glucose medium 
MG + iso. - Minimal-glucose medium plus isoleucine 
(50 /ng/ml) . 
Mean represents three independent experiments. 
Figure 25. Autoradiogram of SDS-polyacrylamide gel 
of lysates from the "Maxicell" 
protocol. Proteins were labeled with 
[35S]methionine and separated on an 5- 
10% SDS polyacrylamide gel. The gel was 
stained in 45% methanol, 0.25% Coomassie 
Blue and 9% acetic acid. After 
destaining in 5% methanol and 7.5% 
acetic acid the gel was dried and 
subjected to autoradiograpghy for 2-3 
days at -70°C. Protein lysates are: 
lane 1; CSR603 lane 2; CSR603/pBR322, 
lane 3; CSR603/pRL258 (ilvA*) . lane 4; 
CSR603/pAW592 ( ilvA+) , lane 5; 
CSR603/pAW589 (leuR) lane 6; 






consistent with the autoradiogram pattern for these 
labeled plasmid lysates (Figure 26). 
Growth Characteristics of AU593 
The growth of ilvA538 strains harboring the various 
plasmids (pBR322, PAW589, pAW592, and pRL258) was measured 
in minimal-glucose medium supplemented with either leucine 
(50 |zg/ml) or valine (100 /ig/ml) after two hour of growth 
(Figures 27 and 28) . Upon leucine supplementation, AU589 
and AU591 including PS1079 exhibited increased growth, but 
growth was inhibited in AU593 similar to the mutant 
PS1150. The wild type, mutant, the ilvA538 transformant 
of pBR322 and AU593 showed growth inhibition in the 
presence of valine; whereas, the ilvA538 clones grew at 
comparable rates. These data suggested that even though 
pRL2 5 8 which contains the known ilvA* gene, this 
recombinant plasmid was unable to confer the resistant 
properties (valR and leuR) to the mutant strain PS1150. 
Figure 26. Densitométrie scan of "Maxicell" 
autoradiogram using LKB laser densitometer. 
A: Lysates containing pBR322, B: Lysates 
containing pRL258, C: Lysates containing 
pAW592, D: Lysates containing pAW589, E: 






Figure 27. Growth of AU593 in minimal-glucose medium 
supplemented with leucine (50 /xg/ml) . Cells 
were grown overnight in minimal-glucose 
medium, inoculated into fresh minimal-glucose 
medium, incubated with aeration at 37°C. 
Growth was measured at indicated times for 
6h. Leucine was added after 2 h of growth. 
Symbols represent strains: PS1079 (*) , PS1150 
















Figure 28. Growth of AU593 in minimal-glucose medium 
supplemented with valine (100 /xg/ml) . Cells 
were grown overnight in minimal-glucose 
medium, inoculated into fresh minimal-glucose 
medium, and incubated with aeration at 37°C. 
Growth was measured at indicated times for 
6 h. Valine was supplemented after 2 h of 
growth. Symbols represent strains: PS1079 
(*), PS1150 (+), AU322 (0), AU589 (#), AU591 
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Previous reports have indicated that a mutation 
(ilvA538.) in the structural gene for threonine deaminase 
resulted in a decrease in the expression of the ilvGMEDA 
operon, and prevented a derepression response of the ilv 
biosynthetic operon to limitation of the branched-chain 
amino acids (Levinthal et al., 1976). Moreover, this 
regulatory mutation decreases the expression and/or 
activity of isoleucyl- and valyl-tRNA synthetases 
(Levinthal et al., 1973 and Levinthal et ai. , 1976) . The 
threonine deaminase in this mutant is hypersensitive to 
feedback inhibition by isoleucine-leucine, thus rendering 
a leucine sensitive growth phenotype. 
To gain further understanding of leucine sensitivity 
in Escherichia coli K-12 strains carrying the ilvA538 
regulatory mutation, two ilvA538 clones were isolated, one 
carrying the leuR gene fragment and the other carrying the 
ilvA* gene fragment of E. coli. These clones, AU589 and 
AU591 respectively, exhibited a leucine-resistant growth 
phenotype and a substantial increase in threonine 
deaminase activity. Data from the differential plot 
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indicated a continuous increase in TD synthesis in both 
clones, suggesting that the elevated levels of TD activity 
were due to new synthesis of the enzyme. 
Surprisingly, in addition to exhibiting leuR and high 
levels of TD activity, both clones (AU589 and AU591) 
displayed a valR growth phenotype. Therefore, several 
spontaneous derivatives (PS1151, leuR; PS1152, valR; 
PS 1153, leuR/valR) of PS1150 ( ilvA538. leus) were isolated 
in order to gain some information about the properties 
expressed by the clones (leuR, valR, and increased levels 
of TD activity). Threonine deaminase levels were 
substantially lower in these derivatives and PS1150 as 
compared to the wild type. Further, genetic mapping data 
suggested that the valR marker of PS1152 is not linked to 
either trp. leu, or to the ilvA gene. The leuR marker of 
PS1151 showed no linkage to the ilvA gene; whereas, the 
leuR marker of PS1153, which is the leuR/valR spontaneous 
derivative showed 31% linkage to the ilvA gene. Also, 
these transductants showed a valR growth phenotype which 
was similar to the clones. Calhoun (1976) reported 
similar results in which several leuR derivatives of PS187 
(ilvA538) were isolated. Two of these spontaneous 
derivatives produced threonine deaminase that was more 
resistant to isoleucine inhibition than the wild type and 
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intermediate between the mutant and the wild type with 
regard to leucine inhibition. These strains exhibited 
lower than normal levels of threonine deaminase and 
dihydroxy acid dehydrase. Some of the other leuR 
derivatives produced increased levels of the 
hypersensitive threonine deaminase. Calhoun concluded 
that leucine sensitivity in an ilvA538 mutant strain may 
be related to threonine deaminase's feedback 
hypersensitivity and the decreased expression of the ilv 
biosynthetic genes. Thus, this regulatory mutation 
appeared to affect the regulatory and catalytic properties 
of threonine deaminase. 
Since the ilvGMEDA operon is regulated by the 
multivalent attenuation mechanism (Landick and Yanofsky, 
1987) , we wanted to determine whether the substantially 
high levels of threonine deaminase activity exhibited by 
both the ilvA538 and the ilvA454 clones could be regulated 
via this control mechanism. Under repressing growth 
conditions, threonine deaminase activity was derepressed 
in the ilvA538 clones, but repressed in the ilvA454 
clones. In the ilvA538 clones, the multivalent 
attenuation control signal was not present which is 
consistent with the ilvA538 mutant strain. Further, the 
differential rate plot of TD synthesis in the ilvA538 
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clones grown under repressed conditions showed continuous 
increase of TD synthesis, which further supports that the 
multivalent attenuation control signal is non-functional 
in these clones. Additionally, TD synthesis in both 
clones grown in the presence of cAMP was continuous, but 
the leuR clone showed an increase in TD synthesis. This 
increase may be the result of cAMP inhibition on 
isoleucyl-tRNA synthetase formation and the activation of 
the PA which contains cAMP binding sites (Lopes et al., 
1989 and Williams et al., 1985). In the ilvA538 clones, 
the high levels of threonine deaminase activity were not 
regulated via the multivalent attenuation control 
mechanism. From these data, it appears that PS1150 may 
contain other mutation(s) since the multivalent 
attenuation control signal was not restored after 
transformation with either recombinant plasmid (leuR or 
putative ilvA*) . 
The plasmids pRL258, pAW592 and pAW589 directed the 
synthesis of a protein, approximately 100 KDa, which may 
represent the dimer form of TD. In addition to the 100 
KDa protein, proteins in the 200 KDa region were 
synthesized by plasmids pAW589 and pAW592, which are 
presumptively the product of the ilvA gene, threonine 
deaminase (tetramer). 
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As mentioned previously, the leuR and putative jlvA* 
DNA fragments expressed leuR, valR, and increased levels 
of threonine deaminase activity. Williams et al. (1985) 
reported the isolation of an E. coli K-12 mutant that was 
growth resistant to valine and simultaneously acquiring 
growth resistant to azaleucine, an analog of leucine. 
Transductional analysis indicated that valR and azlR were 
cotransducible and both linked to leu, ara. and carA. 
This mutant also exhibited increased levels of the ilv 
biosynthetic enzymes as well as isoleucyl- and valyl-tRNA 
synthetases during growth in minimal-glucose and enriched 
media. However, generating vals/azls derivatives of this 
valR/azlR mutant resulted in the restoration of normal 
levels of the ilv biosynthetic enzymes and isoleucyl- and 
valyl-tRNA synthetases. Similarly, the leuR DNA fragment 
exhibited similar properties as the valR/azlR mutant, 
suggesting the possible link between the three genes 
(leuR, valR and ilvA) . The leuR DNA fragment was digested 
with AccI which generated two fragments (0.7 and 0.8 Kbs) . 
These fragments were cloned into pBR322 and used to 
transform PS1150 and CU406 competent cells. These 
subclones conferred leuR, valR, and high levels of 
threonine deaminase activity, indicating that these 
properties were inseparable, which are similar to the 
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characteristics of valR, azlR, and the ilv genes of E. 
coli K-12 mutant strain. Thus, it is possible that both 
fragments consist of tandem repeats which are able to 
confer the three properties. 
Similarly, Hahn and Calhoun (1978) reported data on 
the isolation of spontaneous mutants that were resistant 
to leucine, valine and valine plus glycyl-valine. All of 
the leucine resistant mutants exhibited growth inhibition 
to valine, but produced levels of threonine deaminase that 
were higher than wild type levels. The valine and valine 
plus glycyl-valine resistant mutants were leucine 
resistant and they exhibited increased levels of threonine 
deaminase activity. A MSR91 which was resistant to valine 
plus glycyl-valine was analyzed genetically. In this 
derivative, the synthesis of the ilvEDA gene products was 
constitutive and derepressed about 200 fold in comparison 
to the parent strain. These data suggested that the 
ilvA538 allele had been suppressed. 
Spontaneous mutational studies of PS1150 have shown 
increases in the expression of these three genes (leuR, 
valR, and ilvA). Unexpectedly, recombinant DNA studies 
have revealed that both leuR and putative jlvA* DNA 
fragments were able to complement the ilvA538 and ilvA454 
mutations of PS1150 and CU406, respectively. Also, these 
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DNA fragments conferred a valR ( ilvG*) phenotype to these 
strains. From the data reported here, it is evoked that 
the nucleotide sequences of these fragments are probably 
similar. 
Furthermore, data reported on AU593 (PS1150/pRL258) 
suggested that the ilvA* DNA fragment of Lawther (1987) is 
probably different from the leuR and ilvA* DNA fragments. 
The ilvA1 DNA fragment of Lawther (1987) was unable to 
confer both leuR and valR to the mutant strain PS1150. 
There is a possibility that a protein product of leuR and 
valR genes has the ability to enhance the expression of 
the ilvA gene, which may account for the high levels of 
threonine deaminase activity produced by these clones. 
Riley et al. (1989) reported that a region on the E. coli 
K-12 chromosome between the ilvG gene and the rrnC locus 
codes for an 18 KDa protein. This gene is located 2000 
bp upstream of the ilvG gene. Mutations in the ilvG gene 
that confer valR activate the expression of the 18 KDa 
protein. Platka et al. (1990) demonstrated that a protein 
(43 KDa) binds to the regulatory region of the ilvIH 
operon and enhances its expression. Leucine, on the other 
hand represses its expression by interfering with the 
action of the IHB protein. 
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A Proposed Model of Leucine-Sensitivity in E. coli K-12 
Taken together, from these data, a model is presented 
to account for leucine sensitivity in E. coli K-12 
(Figure 29) . Both the leuR and putative ilvA* clones 
expressed leuR, valR, and elevated levels of TD activity, 
as well as, increased levels of isoleucyl- and valyl-tRNA 
synthetases, but the multivalent attenuation control 
signal was non-functional, which is similar to that of the 
mutant, PS1150. It is suggested that an additional 
mutation may exist in the mutant, PS1150, especially, 
since neither the leuR or putative ilvA* DNA fragment 
restored the multivalent attenuation control signal to the 
mutant strain. Furthermore, this mutant was isolated via 
nitrosoguanidine mutagenesis which has been shown to give 
a high incidence of multiple mutations (Oeschger and 
Berlyn, 1974). Further, it is suggested that the 
catalytic and regulatory properties of TD are located on 
distinct regions on the E. coli K-12 chromosome, since 
both recombinant plasmids restored the catalytic activity 
of TD to the mutant, PS1150, and not the multivalent 
attenuation control signal. Taillon et al., (1988) have 
shown that the ilvA538 mutation resulted in a change in 
base pair 950 (i.e., C -to- T transition) leading to the 
replacement of alanine-317 with valine in the mutant 
Figure 29. A proposed model of leucine-sensitivity in 
E. coli K-12. 
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Proposed Motel of Leucine Sensitivity la 1. coll 1-12 
PS11S0 (11VA538/1OU*) 
amino acids cell growth * * 
Leader Sequence (e,a) 
A 
♦I 10 20 M «0 JO *0 70 
ATTCCTTCCA ACAACATOCA AOAAAACACA AA ATO ACA 00C CTT CTA COA CTC ATT âOC CTO OTC CtO ATT A0C 
IM Iht Alt IM IM An *11 lit •« IM W «al !U Sar 
n M loo no no iso i«o 
CTC CTC CTC ATT ATT ATC CCA CCC TCC OOC OCT OCA CTt <XA COA OOA AAC OCT TAG AfiATCAAOCC 
Val »al Val 11* lia lia f«a fia Cja Cly Ala Ala laa Olf Art Olf Lfa Ala • 
130 IM 170 100 IM MO MO 120 
TTAACCAACT AAOACCCCCO CACCOAAAOO ICCOOOOOTT 
2» «0 MO SM 
ATAACAOCAC AAAATTCTOT TTCTCAAQAT TCAOOMOM 
*1 - Represents llvA538 regulatory mutation in the ilvA gene 
*2 - Represents mutation in the attenuator region of the leader 
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enzyme TD. Additionally, this mutation was located in the 
C-terminal (R2 region) portion of TD and this group of 
amino acids is presumably involved in either the binding 
of isoleucine or subunit interactions. These authors 
suggested that this alteration could either affect the 
binding of isoleucine or the formation of an active TD or 
both (Taillon et al.. 1988). This altered TD may result 
in reduced binding of the substrate, threonine, which in 
turn leads to reduced formation of a-ketobutyrate. 
Further, Singer et al.. (1984) have shown that in vitro 
binding of TD, a-ketobutyrate, isoleucyl-and valyl-tRNA 
synthetases, generated an inactive complex. This binding 
was enhanced with the mutant TD, which suggested that this 
TD probably had acquired a greater affinity for 1RS, VRS, 
and a-ketobutyrate. This observation could explain the 
reduced levels of 1RS and VRS activity in the mutant 
strain. The inactive synthetases are unable to bind 
their substrates, amino acids and/or tRNAs; thereby, 
rendering transcriptional deattenuation of the ileS and 
vais genes. Coleman et al. (1975) reported that the 
branched-chain aminoacyl-tRNA synthetases exhibited 
altered stability of activity and control of synthesis in 
an E. coli strain deleted in the ilvD.-A. and -Ç genes. 
Later, Williams et al. (1978) showed that a deletion 
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strain carrying the AdilvCB bacteriophage had decreased 
levels of the branched-chain aminoacyl-tRNA synthetases; 
also, an ilvA point mutant with a functional ilvA gene, 
the synthetases were increased to levels comparable to 
wild type levels. These results suggested that the 
stability and control of synthesis of these synthetases 
requires the presence of the ilvA gene product, TD. 
Therefore, deattenuation of the ileS and vais genes are 
probably affected because of the mutant enzyme (TD) . 
Thus, in the mutant cells, the reduced levels of a- 
ketobutyrate and TD are divided into two pools: one pool 
is used for the biosynthesis of isoleucine and the other 
one is used in the formation of an inactive complex with 
isoleucyl-and valyl-tRNA synthetases; therefore, this 
would cause a limitation of isoleucine, along with 
isoleucyl- and valyl-tRNA sythetases and their cognate 
tRNAs. This limitation should result in a derepression 
of the ilvGMEDA operon which is consistent with wild type 
E. coli strains (Lawther et al., 1990), but no 
derepression was observed in the mutant (Levinthal et al.. 
1976). These observations suggest an alteration in the 
leader region of the ilvGMEDA operon, since this region 
is required for depression of this operon (Lawther et al., 
1990) . Thus, in order for the mutant strain to growth in 
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minimal-glucose medium, derepression of the operon via the 
internal promoters is necessary to express the genes 
required for the biosynthesis of the branched-chain amino 
acids (Calhoun et al.. 1985; Lopes and Lawther, 1986; 
Lopes and Lawther, 1989; Wek and Hatfield, 1986). 
In summary, when leucine is added to wild type cells 
growing in minimal-glucose medium, a derepression of the 
ilvGMEDA operon occurs owing to an isoleucine-valine 
limitation resulting from the inhibition of acetohydroxy 
acid synthase (AHAS) (Lawther et al., 1987; Platko et al., 
1989; Ricca et al., 1990). However, in the mutant cells, 
derepression is not observed since there is an apparent 
alteration in the attenuator region of the leader. 
Moreover, an altered leader would prevent this operon from 
responding to amino acid limitation via the multivalent 
attenuation control mechanism. We further propose that 
the addition of leucine causes a more stringent limitation 
in the mutant, because of a defective TD which would 
produce a very minute amount of the substrate for AHAS. 
Since these amino acids, isoleucine and valine, are 
substrates for 1RS and VRS, this would limit the amount 
of acylated tRNAlle and tRNAval for protein synthesis (see 
Figure 29). Overall, cell growth in the mutant is reduced 
tremendously, owing to the reduction in the rate of 
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protein synthesis which appears to be tightly coupled to 
the growth rate of bacterial cells (Hershey, 1987). 
CHAPTER VI 
SUMMARY AND CONCLUSIONS 
1. To gain further understanding of leucine- 
sensitivity in Escherichia coli K-12, two 
recombinant plasmids were isolated; one carrying 
the leuR DNA fragment and the other carrying the 
putative ilvA* DNA fragment. 
2. Threonine deaminase (ilvA gene product) activity 
was elevated in the mutant strain subsequent to 
transformation with either leuR or putative ilvA* 
recombinant plasmid. 
3. The expression of the ilvA gene and isoleucyl- and 
valyl-tRNA synthetases was restored to normal 
levels in the ilvA538 mutant strain subsequent to 
transformation with either recombinant plasmid. 
4. The multivalent attenuation control mechanism 
appeared non-functional in the mutant PS1150, as 
well as, in PS1150 transformants, suggesting that 
there may be an additional mutation(s) responsible 
for the altered control of TD expression. 
5. Transformants generated by normal pBR322 did not 
exhibit any apparent effect upon the enzyme levels 
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within this ilvA538 mutant strain or on the its 
growth characteristics. 
Both classes of transformants (AU589 and AU591) 
acquired a valine-resistant growth phenotype, but 
the pBR322 transformant maintained its valine- 
sensitive growth phenotype similar to the mutant 
strain. 
The spontaneous derivatives (leuR, valR, leuR/valR) 
of the leus mutant grew at comparable rates in 
minimal-glucose medium and minimal-glucose 
supplemented with the respective amino acid. 
The valine-resistant derivative exhibited growth 
inhibition upon leucine supplementation, 
suggesting that the leucine sensitive growth 
phenotype remained. 
The leucine-resistant derivative exhibited growth 
inhibition upon valine supplementation, suggesting 
that the valine-sensitive growth phenotype 
remained. 
All of these spontaneous derivatives exhibited low 
levels of threonine deaminase activity suggesting 
that they still possessed the ilvA538 allele. 
PI transduction studies indicated 31% linkage of 
the leuR/valR marker to TD activity which is 
consistent with the properties exhibited by the 
clones. 
Second generation transformants, derived from the 
primary DNA inserts (1.5 Kb and 0.5 Kb) exhibited 
identical properties equivalent to the original 
clones (i.e.,leuR, valR, and increased threonine 
deaminase activity). 
Subclones (0.7 and 0.8 Kb) generated from the 1.5 
Kb fragment conferred the same three properties 
as of the original clone. 
The leuR and putative ilvA* recombinant plasmids 
appeared to direct the synthesis of proteins in 
the 100 and 200 KDa range in contrast to that of 
pBR322 containing lysates. 
Transformants generated from pRL258 of Lawther 
exhibited high levels of threonine deaminase 
activity as expected, but the resistant properties 
were not conferred. This observation suggested 
that the resistant properties exhibited by pAW589 
and pAW592 may influence threonine deaminase 
activity. 
Finally, based on these data, we propose a model 
to account for leucine-sensitivity in this unique 
mutant strain (PS1150) of Escherichia coli K-12. 
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Succinctly, this model states the following: (i) 
When leucine is added to wild type cells growing 
in minimal-glucose medium, a derepression of the 
ilvGMEDA operon occurs owing to an isoleucine- 
valine limitation resulting from the inhibition 
of acetohydroxy acid synthase (AHAS). (ii) In the 
mutant cells, derepression is not observed since 
there is an apparent alteration in the attenuator 
region of the leader. 
(iii) An altered leader would prevent this operon 
from responding to amino acid limitation via the 
multivalent attenuation control mechanism. 
(iv) The addition of leucine causes a more 
stringent limitation in the mutant, because of a 
defective TD which would produce a very minute 
amount of the substrate for AHAS. 
(v) Since valine and isoleucine are substrates for 
1RS and VRS, this would limit the amount of 
acylated tRNAlle and tRNAval for protein synthesis 
(see Figure 29). 
(vi) Overall, cell growth in the mutant is reduced 
tremendously, owing to the reduction in the rate 
of protein synthesis which appears to be tightly 
coupled to the growth rate. 
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